{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "medicinal plants", "neurological diseases treatment", "phytochemicals"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37109528", "DateRevised": {"Year": "2023", "Month": "05", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "04", "Day": "12"}], "Language": ["eng"], "ELocationID": ["999", "10.3390/life13040999"], "Journal": {"ISSN": "2075-1729", "JournalIssue": {"Volume": "13", "Issue": "4", "PubDate": {"Year": "2023", "Month": "Apr", "Day": "12"}}, "Title": "Life (Basel, Switzerland)", "ISOAbbreviation": "Life (Basel)"}, "ArticleTitle": "Phytochemicals: A Promising Alternative for the Prevention of Alzheimer's Disease.", "Abstract": {"AbstractText": ["Alzheimer's disease (AD) is a neurological condition that worsens with ageing and affects memory and cognitive function. Presently more than 55 million individuals are affected by AD all over the world, and it is a leading cause of death in old age. The main purpose of this paper is to review the phytochemical constituents of different plants that are used for the treatment of AD. A thorough and organized review of the existing literature was conducted, and the data under the different sections were found using a computerized bibliographic search through the use of databases such as PubMed, Web of Science, Google Scholar, Scopus, CAB Abstracts, MEDLINE, EMBASE, INMEDPLAN, NATTS, and numerous other websites. Around 360 papers were screened, and, out of that, 258 papers were selected on the basis of keywords and relevant information that needed to be included in this review. A total of 55 plants belonging to different families have been reported to possess different bioactive compounds (galantamine, curcumin, silymarin, and many more) that play a significant role in the treatment of AD. These plants possess anti-inflammatory, antioxidant, anticholinesterase, and anti-amyloid properties and are safe for consumption. This paper focuses on the taxonomic details of the plants, the mode of action of their phytochemicals, their safety, future prospects, limitations, and sustainability criteria for the effective treatment of AD."]}, "AuthorList": [{"Identifier": ["0000-0002-8409-3624"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Lovely Professional University, Phagwara 144411, Punjab, India."}], "LastName": "Koul", "ForeName": "Bhupendra", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botany, Lovely Professional University, Phagwara 144411, Punjab, India."}], "LastName": "Farooq", "ForeName": "Usma", "Initials": "U"}, {"Identifier": ["0000-0003-4047-7236"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Life Sciences, Yeungnam University, Gyeongsan 38541, Republic of Korea."}], "LastName": "Yadav", "ForeName": "Dhananjay", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Life Sciences, Yeungnam University, Gyeongsan 38541, Republic of Korea."}], "LastName": "Song", "ForeName": "Minseok", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Life (Basel)", "NlmUniqueID": "101580444", "ISSNLinking": "2075-1729"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Haque R.U., Levey A.I. Alzheimer\u2019s disease: A clinical perspective and future nonhuman primate research opportunities. Proc. Natl. Acad. Sci. USA. 2019;116:26224\u201326229. doi: 10.1073/pnas.1912954116.", "ArticleIdList": ["10.1073/pnas.1912954116", "PMC6936673", "31871211"]}, {"Citation": "Sosa-Ortiz A.L., Acosta-Castillo I., Prince M.J. Epidemiology of dementias and Alzheimer\u2019s disease. Arch. Med. Res. 2012;43:600\u2013608. doi: 10.1016/j.arcmed.2012.11.003.", "ArticleIdList": ["10.1016/j.arcmed.2012.11.003", "23159715"]}, {"Citation": "Kaj B., de Leon M.J., Zetterberg H. Alzheimer\u2019s disease. Lancet. 2006;368:387\u2013403.", "ArticleIdList": ["16876668"]}, {"Citation": "World Health Organization: Dementia. 2019.  [(accessed on 20 December 2021)].  Available online:  https://www.who.int/en/news\u2013room/factsheets/detail/dementia."}, {"Citation": "Prince M., Guerchet M., Prina M. Ph.D. Thesis. Alzheimer\u2019s Disease International; London, UK: 2013. Policy Briefs for Heads of Governments. D."}, {"Citation": "Cumming T., Brodtmann A. Dementia and stroke: The present and future epidemic. Int. J. Stroke. 2010;5:453\u2013454. doi: 10.1111/j.1747-4949.2010.00527.x.", "ArticleIdList": ["10.1111/j.1747-4949.2010.00527.x", "21050400"]}, {"Citation": "Marde V.S., Tiwari P.L., Wankhede N.L., Taksande B.G., Upaganlawar A.B., Umekar M.J., Kale M.B. Neurodegenerative disorders associated with genes of mitochondria. Future J. Pharm. Sci. 2021;7:1\u20138. doi: 10.1186/s43094-021-00215-5.", "ArticleIdList": ["10.1186/s43094-021-00215-5"]}, {"Citation": "Nunomura A., Perry G., Hirai K., Aliev G., Takeda A., Chiba S., Smith M.A. Neuronal RNA oxidation in Alzheimer\u2019s disease and Down\u2019s syndrome. Ann. N.Y. Acad. Sci. 1999;893:362\u2013364. doi: 10.1111/j.1749-6632.1999.tb07855.x.", "ArticleIdList": ["10.1111/j.1749-6632.1999.tb07855.x", "10672267"]}, {"Citation": "Zhao Y., Zhao B. Oxidative stress and the pathogenesis of Alzheimer\u2019s disease. Oxid. Med. Cell. Longev. 2013;2013:316523. doi: 10.1155/2013/316523.", "ArticleIdList": ["10.1155/2013/316523", "PMC3745981", "23983897"]}, {"Citation": "Wattmo C., Minthon L., Wallin \u00c5.K. Mild versus moderate stages of Alzheimer\u2019s disease: Three\u2013year outcomes in a routine clinical setting of cholinesterase inhibitor therapy. Alzheimer\u2019s Res. Ther. 2016;8:1\u201315. doi: 10.1186/s13195-016-0174-1.", "ArticleIdList": ["10.1186/s13195-016-0174-1", "PMC4756534", "26883213"]}, {"Citation": "Chauhan P.S., Mishra M., Koul B., Sharma M., Yadav D. Modifiable risk factors associated with Alzheimer\u2019s disease with special reference to sleep disturbance. CNS Neurol. Disord. Drug Targets. 2021;20:594\u2013601. doi: 10.2174/1871527320666210319111852.", "ArticleIdList": ["10.2174/1871527320666210319111852", "33745437"]}, {"Citation": "Heneka M.T., Carson M.J., Khoury J.E., Landreth G.E., Brosseron F., Feinstein D.L., Jacobs A.H., Wyss-Coray T., Vitorica J., Ransohoff R.M., et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14:388\u2013405. doi: 10.1016/S1474-4422(15)70016-5.", "ArticleIdList": ["10.1016/S1474-4422(15)70016-5", "PMC5909703", "25792098"]}, {"Citation": "Huang W.J., Zhang X., Chen W.W. Role of oxidative stress in Alzheimer\u2019s disease. Biomed. Rep. 2016;4:519\u2013522. doi: 10.3892/br.2016.630.", "ArticleIdList": ["10.3892/br.2016.630", "PMC4840676", "27123241"]}, {"Citation": "Karch C.M., Cruchaga C., Goate A.M. Alzheimer\u2019s Disease Genetics: From the Bench to the Clinic. Neuron. 2014;83:11\u201326. doi: 10.1016/j.neuron.2014.05.041.", "ArticleIdList": ["10.1016/j.neuron.2014.05.041", "PMC4120741", "24991952"]}, {"Citation": "Chin-Chan M., Navarro-Yepes J., Quintanilla-Vega B. Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Front. Cell. Neurosci. 2015;9:124. doi: 10.3389/fncel.2015.00124.", "ArticleIdList": ["10.3389/fncel.2015.00124", "PMC4392704", "25914621"]}, {"Citation": "Doroszkiewicz J., Mroczko B. New possibilities in the therapeutic approach to Alzheimer\u2019s Disease. Int. J. Mol. Sci. 2022;23:8902. doi: 10.3390/ijms23168902.", "ArticleIdList": ["10.3390/ijms23168902", "PMC9409036", "36012193"]}, {"Citation": "Wilson B., Geetha K.M. Neurotherapeutic applications of nanomedicine for treating Alzheimer\u2019s disease. J. Control Release. 2020;325:25\u201337. doi: 10.1016/j.jconrel.2020.05.044.", "ArticleIdList": ["10.1016/j.jconrel.2020.05.044", "32473177"]}, {"Citation": "Barage S.H., Sonawane K.D. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer\u2019s disease. Neuropeptides. 2015;52:1\u201318. doi: 10.1016/j.npep.2015.06.008.", "ArticleIdList": ["10.1016/j.npep.2015.06.008", "26149638"]}, {"Citation": "Maresova P., Mohelska H., Dolejs J., Kuca K. Socio\u2013economic aspects of Alzheimer\u2019s disease. Curr. Alzheimer Res. 2015;12:903\u2013911. doi: 10.2174/156720501209151019111448.", "ArticleIdList": ["10.2174/156720501209151019111448", "26510983"]}, {"Citation": "Loureiro J.A., Gomes B., Coelho M.A., do Carmo Pereira M., Rocha S. Targeting nanoparticles across the blood\u2013brain barrier with monoclonal antibodies. Nanomedicine. 2014;9:709\u2013722. doi: 10.2217/nnm.14.27.", "ArticleIdList": ["10.2217/nnm.14.27", "24827845"]}, {"Citation": "Loureiro J.A., Gomes B., Fricker G., Coelho M.A.N., Rocha S., Pereira M.C. Cellular uptake of PLGA nanoparticles targeted with anti\u2013amyloid and anti\u2013transferrin receptor antibodies for Alzheimer\u2019s disease treatment. Colloids Surf. B Biointerfaces. 2016;145:8\u201313. doi: 10.1016/j.colsurfb.2016.04.041.", "ArticleIdList": ["10.1016/j.colsurfb.2016.04.041", "27131092"]}, {"Citation": "Islam M.A., Khandker S.S., Alam F., Khalil M.I., Kamal M.A., Gan S.H. Alzheimer\u2019s Disease and Natural Products: Future Regiments Emerging from Nature. Curr. Top. Med. Chem. 2017;17:1408\u20131428.", "ArticleIdList": ["28049401"]}, {"Citation": "Chauhan P.S., Yadav D., Arukha A.P. Dietary Nutrients and Prevention of Alzheimer\u2019s disease. CNS Neurol. Disord.-Drug Targets (Former. Curr. Drug Targets-CNS Neurol. Disord.) 2022;21:217\u2013227. doi: 10.2174/1871527320666210405141123.", "ArticleIdList": ["10.2174/1871527320666210405141123", "33820525"]}, {"Citation": "Shafi O. Inverse relationship between Alzheimer\u2019s disease and cancer, and other factors contributing to Alzheimer\u2019s disease: A systematic review. BMC Neurol. 2016;16:1\u201317. doi: 10.1186/s12883-016-0765-2.", "ArticleIdList": ["10.1186/s12883-016-0765-2", "PMC5120447", "27875990"]}, {"Citation": "Scheltens P., Strooper B.D., Kivipelto M., Holstege H., Ch\u00e9telat G., Teunissen C.E., Cummings J., van der Flier W.M. Alzheimer\u2019s disease. Lancet. 2021;397:1577\u20131590. doi: 10.1016/S0140-6736(20)32205-4.", "ArticleIdList": ["10.1016/S0140-6736(20)32205-4", "PMC8354300", "33667416"]}, {"Citation": "Scarmeas N., Anastasiou C.A., Yannakoulia M. Nutrition and prevention of cognitive impairment. Lancet Neurol. 2018;17:1006\u20131015. doi: 10.1016/S1474-4422(18)30338-7.", "ArticleIdList": ["10.1016/S1474-4422(18)30338-7", "30244829"]}, {"Citation": "Imhof A., K\u00f6vari E., Gunten A.V., Gold G., Rivara C.B., Herrmann F.R., Hof P.R., Bouras C., Giannakopoulos P. Morphological substrates of cognitive decline in nonagenarians and centenarians: A new paradigm? J. Neurol. Sci. 2007;257:72\u201379. doi: 10.1016/j.jns.2007.01.025.", "ArticleIdList": ["10.1016/j.jns.2007.01.025", "17303173"]}, {"Citation": "Heneka M.T., Nadrigny F., Regen T., Martinez-Hernandez A., Dumitrescu-Ozimek L., Terwel D., Jardanhazi-Kurutz D., Walter J., Kirchhoff F., Hanisch U., et al. Locus ceruleus controls Alzheimer\u2019s disease pathology by modulating microglial functions through norepinephrine. Proc. Natl. Acad. Sci. USA. 2010;107:6058\u20136063. doi: 10.1073/pnas.0909586107.", "ArticleIdList": ["10.1073/pnas.0909586107", "PMC2851853", "20231476"]}, {"Citation": "Grudzien A., Shaw P., Weintraub S., Bigio E., Mash D.C., Mesulam M.M. Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer\u2019s disease. Neurobiol. Aging. 2007;28:327\u2013335. doi: 10.1016/j.neurobiolaging.2006.02.007.", "ArticleIdList": ["10.1016/j.neurobiolaging.2006.02.007", "16574280"]}, {"Citation": "Sims N.R., Bowen D.M. Alzheimer\u2019s Disease: The Standard Reference. MacMillan; New York, NY, USA: 1983. Changes in choline acetyltransferase and in acetylcholine synthesis; pp. 37\u201345."}, {"Citation": "Whitehouse P.J., Price D.L., Clark A.W., Coyle J.T., DeLong M.R. Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. Off. J. Am. Neurol. Assoc. Child Neurol. Soc. 1981;10:122\u2013126. doi: 10.1002/ana.410100203.", "ArticleIdList": ["10.1002/ana.410100203", "7283399"]}, {"Citation": "Morrison J.H., Hof P.R. Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer\u2019s disease. Prog. Brain Res. 2002;136:467\u2013486.", "ArticleIdList": ["12143403"]}, {"Citation": "Bowen D.M., Francis P.T., Palmer A.M. Advancing Frontiers in Alzheimer\u2019s Disease Research. University of Texas Press; Austin, TX, USA: 1987. The biochemistry of cortical and subcortical neurons in Alzheimer\u2019s disease; pp. 11\u201326."}, {"Citation": "Stricker N.H., Schweinsburg B.C., Delano-Wood L., Wierenga C.E., Bangen K.J., Haaland K.Y., Frank L.R., Salmon D.P., Bondi M.W. Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer\u2019s disease supports retrogenesis. Neuroimage. 2009;45:10\u201316. doi: 10.1016/j.neuroimage.2008.11.027.", "ArticleIdList": ["10.1016/j.neuroimage.2008.11.027", "PMC2782417", "19100839"]}, {"Citation": "Delatour B., Blanchard V., Pradier L., Duyckaerts C. Alzheimer pathology disorganizes cortico-cortical circuitry: Direct evidence from a transgenic animal model. Neurobiol. Dis. 2004;16:41\u201347. doi: 10.1016/j.nbd.2004.01.008.", "ArticleIdList": ["10.1016/j.nbd.2004.01.008", "15207260"]}, {"Citation": "Scheff S.W., Price D.A. Synapse loss in the temporal lobe in Alzheimer\u2019s disease. Ann. Neurol. Off. J. Am. Neurol. Assoc. Child Neurol. Soc. 1993;33:190\u2013199. doi: 10.1002/ana.410330209.", "ArticleIdList": ["10.1002/ana.410330209", "8434881"]}, {"Citation": "Gupta V.B., Anitha S., Hegde M.L., Zecca L., Garruto R.M., Ravid R., Shankar S.K., Stein R., Shanmugavelu P., Rao K.S.J. Aluminium in Alzheimer\u2019s disease: Are we still at a crossroad? Cell. Mol. Life Sci. 2005;62:143\u2013158. doi: 10.1007/s00018-004-4317-3.", "ArticleIdList": ["10.1007/s00018-004-4317-3", "15666086"]}, {"Citation": "Armstrong R.A. What causes Alzheimer\u2019s disease? Folia Neuropathol. 2013;51:169\u2013188. doi: 10.5114/fn.2013.37702.", "ArticleIdList": ["10.5114/fn.2013.37702", "24114635"]}, {"Citation": "Mirza A., King A., Troakes C., Exley C. Aluminium in brain tissue in familial Alzheimer\u2019s disease. J. Trace Elem. Med. Biol. 2017;40:30\u201336. doi: 10.1016/j.jtemb.2016.12.001.", "ArticleIdList": ["10.1016/j.jtemb.2016.12.001", "28159219"]}, {"Citation": "Giunta B., Obregon D., Velisetty R., Sanberg P.R., Borlongan C.V., Tan J. The immunology of traumatic brain injury: A prime target for Alzheimer\u2019s disease prevention. J. Neuroinflamm. 2012;9:1\u20138. doi: 10.1186/1742-2094-9-185.", "ArticleIdList": ["10.1186/1742-2094-9-185", "PMC3458981", "22849382"]}, {"Citation": "Rasmusson D.X., Brandt J., Brandt Martin D.B., Folstein M.F. Head injury as a risk factor in Alzheimer\u2019s disease. Brain Inj. 1995;9:213\u2013219. doi: 10.3109/02699059509008194.", "ArticleIdList": ["10.3109/02699059509008194", "7606235"]}, {"Citation": "Plassman B.L., Havlik R.J., Steffens D.C., Helms M.J., Newman T.N., Drosdick D., Phillips D.C., Gau B.A., Welsh-Bohmer K.A., Burke J.R., et al. Documented head injury in early adulthood and risk of Alzheimer\u2019s disease and other dementias. Neurology. 2000;55:1158\u20131166. doi: 10.1212/WNL.55.8.1158.", "ArticleIdList": ["10.1212/WNL.55.8.1158", "11071494"]}, {"Citation": "Takizawa C., Gemmell E., Kenworthy J., Speyer R. A systematic review of the prevalence of oropharyngeal dysphagia in stroke, Parkinson\u2019s disease, Alzheimer\u2019s disease, head injury, and pneumonia. Dysphagia. 2016;31:434\u2013441. doi: 10.1007/s00455-016-9695-9.", "ArticleIdList": ["10.1007/s00455-016-9695-9", "26970760"]}, {"Citation": "Amarya S., Singh K., Sabharwal M. Changes during aging and their association with malnutrition. J. Clin. Gerontol. Geriatr. 2015;6:78\u201384. doi: 10.1016/j.jcgg.2015.05.003.", "ArticleIdList": ["10.1016/j.jcgg.2015.05.003"]}, {"Citation": "Roque M., Salva A., Vellas B. Malnutrition in community\u2013dwelling adults with dementia (NutriAlz Trial) J. Nutr. Health Aging. 2013;17:295\u2013299. doi: 10.1007/s12603-012-0401-9.", "ArticleIdList": ["10.1007/s12603-012-0401-9", "23538648"]}, {"Citation": "Fleminger S., Oliver D.L., Lovestone S., Rabe-Hesketh S., Giora A. Head injury as a risk factor for Alzheimer\u2019s disease: The evidence 10 years on; a partial replication. J. Neurol. Neurosurg. Psychiatry. 2003;74:857\u2013862. doi: 10.1136/jnnp.74.7.857.", "ArticleIdList": ["10.1136/jnnp.74.7.857", "PMC1738550", "12810767"]}, {"Citation": "Hu N., Yu J.T., Tan L., Wang Y.L., Sun L., Tan L. Nutrition and the risk of Alzheimer\u2019s disease. Biomed. Res. Int. 2013;2013:524820. doi: 10.1155/2013/524820.", "ArticleIdList": ["10.1155/2013/524820", "PMC3705810", "23865055"]}, {"Citation": "Abate G., Marziano M., Rungratanawanich W., Memo M., Uberti D. Nutrition and AGE\u2013ing: Focusing on Alzheimer\u2019s disease. Oxidative Med. Cell. Longev. 2017;2017:7039816. doi: 10.1155/2017/7039816.", "ArticleIdList": ["10.1155/2017/7039816", "PMC5266861", "28168012"]}, {"Citation": "Koyama A., Hashimoto M., Tanaka H., Fujise N., Matsushita M., Miyagawa Y., Hatada Y., Fukuhara R., Hasegawa N., Todani S., et al. Malnutrition in Alzheimer\u2019s disease, dementia with lewy bodies, and frontotemporal lobar degeneration: Comparison using serum albumin, total protein, and hemoglobin level. PLoS ONE. 2016;11:e0157053. doi: 10.1371/journal.pone.0157053.", "ArticleIdList": ["10.1371/journal.pone.0157053", "PMC4919003", "27336725"]}, {"Citation": "Wiseman F.K., Al-Janabi T., Hardy J., Karmiloff-Smith A., Nizeticgoate D., Tybulewicz V.L.J., Fisher E.M.C., Strydom A. A genetic cause of Alzheimer disease: Mechanistic insights from Down syndrome. Nat. Rev. Neurosci. 2015;16:564\u2013574. doi: 10.1038/nrn3983.", "ArticleIdList": ["10.1038/nrn3983", "PMC4678594", "26243569"]}, {"Citation": "Zhang Y.W., Thompson R., Zhang H., Xu H. APP processing in Alzheimer\u2019s disease. Mol. Brain. 2011;4:1\u201313. doi: 10.1186/1756-6606-4-3.", "ArticleIdList": ["10.1186/1756-6606-4-3", "PMC3022812", "21214928"]}, {"Citation": "Delacourte A., Sergeant N., Champain D., Wattez A., Maurage C.A., Maurage Lebert F., Pasquier F., David J.P. Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer\u2019s disease. Neurology. 2002;59:398\u2013407. doi: 10.1212/WNL.59.3.398.", "ArticleIdList": ["10.1212/WNL.59.3.398", "12177374"]}, {"Citation": "Kabir M.T., Uddin M.S., Setu J.R., Ashraf G.M., Bin-Jumah M.N., Abdel-Daim M.M. Exploring the role of PSEN mutations in the pathogenesis of Alzheimer\u2019s disease. Neurotox. Res. 2020;38:833\u2013849. doi: 10.1007/s12640-020-00232-x.", "ArticleIdList": ["10.1007/s12640-020-00232-x", "32556937"]}, {"Citation": "Moro M.L., Giaccone G., Lombardi R., Indaco A., Uggetti A., Morbin M., Saccucci S., Fede G.D., Catania M., Walsh D.M., et al. APP mutations in the A\u03b2 coding region are associated with abundant cerebral deposition of A\u03b238. Acta Neuropathol. 2012;124:809\u2013821. doi: 10.1007/s00401-012-1061-x.", "ArticleIdList": ["10.1007/s00401-012-1061-x", "23143229"]}, {"Citation": "De Strooper B. Loss-of-function presenilin mutations in Alzheimer disease: Talking Point on the role of presenilin mutations in Alzheimer disease. EMBO Rep. 2007;8:141\u2013146. doi: 10.1038/sj.embor.7400897.", "ArticleIdList": ["10.1038/sj.embor.7400897", "PMC1796779", "17268505"]}, {"Citation": "Godfrey M.E., Wojcik D.P., Krone C.A. Apolipoprotein E genotyping as a potential biomarker for mercury neurotoxicity. J. Alzheimer\u2019s Dis. 2003;5:189\u2013195. doi: 10.3233/JAD-2003-5303.", "ArticleIdList": ["10.3233/JAD-2003-5303", "12897404"]}, {"Citation": "Yamazaki Y., Painter M.M., Bu G., Kanekiyo T. Apolipoprotein E as a therapeutic target in Alzheimer\u2019s disease: A review of basic research and clinical evidence. CNS Drugs. 2016;30:773\u2013789. doi: 10.1007/s40263-016-0361-4.", "ArticleIdList": ["10.1007/s40263-016-0361-4", "PMC5526196", "27328687"]}, {"Citation": "Fern\u00e1ndez-Calle R., Konings S.C., Fronti\u00f1\u00e1n-Rubio J., Garc\u00eda-Revilla J., Camprub\u00ed-Ferrer L., Svensson M., Martinson I., Boza-Serrano A., Venero J.L., Nielsen H.M., et al. APOE in the bullseye of neurodegenerative diseases: Impact of the APOE genotype in Alzheimer\u2019s disease pathology and brain diseases. Mol. Neurodegener. 2022;17:62. doi: 10.1186/s13024-022-00566-4.", "ArticleIdList": ["10.1186/s13024-022-00566-4", "PMC9509584", "36153580"]}, {"Citation": "Liu C.C., Kanekiyo T., Xu H., Bu G. Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy. Nat. Rev. Neurol. 2013;9:106\u2013118. doi: 10.1038/nrneurol.2012.263.", "ArticleIdList": ["10.1038/nrneurol.2012.263", "PMC3726719", "23296339"]}, {"Citation": "Castellani R., Hirai K., Aliev G., Drew K.L., Nunomura A., Takeda A., Cash A.D., Obrenovich M.E., Perry G., Smith M.A. Role of mitochondrial dysfunction in Alzheimer\u2019s disease. J. Neurosci. Res. 2002;70:357\u2013360. doi: 10.1002/jnr.10389.", "ArticleIdList": ["10.1002/jnr.10389", "12391597"]}, {"Citation": "Gibson G.E., Sheu K.F.R., Blass J.P. Abnormalities of mitochondrial enzymes in Alzheimer disease. J. Neural Transm. 1998;105:855\u2013870. doi: 10.1007/s007020050099.", "ArticleIdList": ["10.1007/s007020050099", "9869323"]}, {"Citation": "Wang X., Su B., Zheng L., Perry G., Smith M.A., Zhu X. The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer\u2019s disease. J. Neurochem. 2009;109:153\u2013159. doi: 10.1111/j.1471-4159.2009.05867.x.", "ArticleIdList": ["10.1111/j.1471-4159.2009.05867.x", "PMC2720030", "19393022"]}, {"Citation": "Yamane T., Ikari Y., Nishio T., Ishii K., Kato T., Ito K., Silverman D.H.S., Senda M., Asada T., Arai H., et al. Visual-statistical interpretation of 18F\u2013FDG\u2013PET images for characteristic Alzheimer patterns in a multicenter study: Inter\u2013rater concordance and relationship to automated quantitative evaluation. AJNR Am. J. Neuroradiol. 2014;35:244\u2013249. doi: 10.3174/ajnr.A3665.", "ArticleIdList": ["10.3174/ajnr.A3665", "PMC7965770", "23907243"]}, {"Citation": "Shokouhi S., Claassen D., Kang H., Ding Z., Rogers B., Mishra A., Riddle W.R., Alzheimer\u2019s Disease Neuroimaging Initiative Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F\u2013FDG PET. J. Nucl. Med. 2013;54:1564\u20131569. doi: 10.2967/jnumed.112.116137.", "ArticleIdList": ["10.2967/jnumed.112.116137", "PMC4134885", "23864720"]}, {"Citation": "Landau S.M., Harvey D., Madison C.M., Koeppe R.A., Reiman E.M., Foster N.L., Weiner M.W., Jagust W.J., Alzheimer\u2019s Disease Neuroimaging Initiative Associations between cognitive, functional, and FDG\u2013PET measures of decline in AD and MCI. Neurobiol. Aging. 2011;32:1207\u20131218. doi: 10.1016/j.neurobiolaging.2009.07.002.", "ArticleIdList": ["10.1016/j.neurobiolaging.2009.07.002", "PMC2891865", "19660834"]}, {"Citation": "Cottrell D.A., Blakely E.L., Johnson M.A., Ince P.G., Turnbull D.M. Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD. Neurology. 2001;57:260\u2013264. doi: 10.1212/WNL.57.2.260.", "ArticleIdList": ["10.1212/WNL.57.2.260", "11468310"]}, {"Citation": "Gibson G.E., Chen H.L., Xu H., Qiu L., Xu Z., Denton T.T., Shi Q. Deficits in the mitochondrial enzyme \u03b1\u2013ketoglutarate dehydrogenase lead to Alzheimer\u2019s disease\u2013like calcium dysregulation. Neurobiol. Aging. 2012;33:1121.e13\u20131121.e24. doi: 10.1016/j.neurobiolaging.2011.11.003.", "ArticleIdList": ["10.1016/j.neurobiolaging.2011.11.003", "PMC3321099", "22169199"]}, {"Citation": "Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R.L., Atwood C.S., Johnson A.B., Kress y., Vinters H.V., Tabaton M., et al. Mitochondrial abnormalities in Alzheimer\u2019s disease. J. Neurosci. 2001;21:3017\u20133023. doi: 10.1523/JNEUROSCI.21-09-03017.2001.", "ArticleIdList": ["10.1523/JNEUROSCI.21-09-03017.2001", "PMC6762571", "11312286"]}, {"Citation": "Mecocci P., MacGarvey U., Beal F.M. Oxidative damage to mitochondrial DNA is increased in Alzheimer\u2019s disease. Ann. Neurol. Off. J. Am. Neurol. Assoc. Child Neurol. Soc. 1994;36:747\u2013751. doi: 10.1002/ana.410360510.", "ArticleIdList": ["10.1002/ana.410360510", "7979220"]}, {"Citation": "Launer L.J., Ross G.W., Petrovitch H., Masaki K., Foley D., White L.R., Havlik R.J. Havlik. Midlife blood pressure and dementia: The Honolulu-Asia aging study. Neurobiol. Aging. 2000;21:49\u201355. doi: 10.1016/S0197-4580(00)00096-8.", "ArticleIdList": ["10.1016/S0197-4580(00)00096-8", "10794848"]}, {"Citation": "Snyder H.M., Corriveau R.A., Craft S., Faber J.E., Greenberg S.M., Knopman D., Lamb B.T., Montine T.J., Nedergaard M., Schaffer C.B., et al. Vascular contributions to cognitive impairment and dementia including Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2015;11:710\u2013717. doi: 10.1016/j.jalz.2014.10.008.", "ArticleIdList": ["10.1016/j.jalz.2014.10.008", "PMC4731036", "25510382"]}, {"Citation": "Helzner E.P., Luchsinger J.A., Scarmeas N., Cosentino S., Brickman A.M., Glymour M.M., Stern Y. Contribution of vascular risk factors to the progression in Alzheimer disease. Arch. Neurol. 2009;66:343\u2013348. doi: 10.1001/archneur.66.3.343.", "ArticleIdList": ["10.1001/archneur.66.3.343", "PMC3105324", "19273753"]}, {"Citation": "Kivipelto M., Helkala E.L., Laakso M.P., H\u00e4nninen T., Hallikainen M., Alhainen K., Soininen H., Tuomilehto J., Nissinen A. Midlife vascular risk factors and Alzheimer\u2019s disease in later life: Longitudinal, population-based study. Bmj. 2001;322:1447\u20131451. doi: 10.1136/bmj.322.7300.1447.", "ArticleIdList": ["10.1136/bmj.322.7300.1447", "PMC32306", "11408299"]}, {"Citation": "Deane R., Yan S.D., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., YU J., et al. RAGE mediates amyloid\u2013\u03b2 peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 2003;9:907\u2013913. doi: 10.1038/nm890.", "ArticleIdList": ["10.1038/nm890", "12808450"]}, {"Citation": "Eikelenboom P., Stam F.C. Immunoglobulins and complement factors in senile plaques: An immunoperoxidase study. Acta Neuropathol. 1982;57:239\u2013242. doi: 10.1007/BF00685397.", "ArticleIdList": ["10.1007/BF00685397", "6812382"]}, {"Citation": "Heinonen O., Syrj\u00e4nen S., Soininen H., Talasniemi S., Kaski M., M\u00e4ntyj\u00e4rvi R., Syrj\u00e4nen K., Riekkinen P. Circulating immune complexes in sera from patients with Alzheimer\u2019s disease, multi\u2013infarct dementia and Down\u2019s syndrome. Neurosci. Lett. 1993;149:67\u201370. doi: 10.1016/0304-3940(93)90349-P.", "ArticleIdList": ["10.1016/0304-3940(93)90349-P", "8469384"]}, {"Citation": "Veerhuis R. Histological and direct evidence for the role of complement in the neuroinflammation of AD. Curr. Alzheimer Res. 2011;8:34\u201358. doi: 10.2174/156720511794604589.", "ArticleIdList": ["10.2174/156720511794604589", "21143154"]}, {"Citation": "Acharya N.K., Nagele E.P., Han M., Coretti N.J., DeMarshall C., Kosciuk M.C., Boulos P.A., Nagele R.G. Neuronal PAD4 expression and protein citrullination: Possible role in production of autoantibodies associated with neurodegenerative disease. J. Autoimmune. 2012;38:369\u2013380. doi: 10.1016/j.jaut.2012.03.004.", "ArticleIdList": ["10.1016/j.jaut.2012.03.004", "22560840"]}, {"Citation": "Miklossy J. Emerging roles of pathogens in Alzheimer disease. Expert Rev. Mol. 2011;13:e30. doi: 10.1017/S1462399411002006.", "ArticleIdList": ["10.1017/S1462399411002006", "21933454"]}, {"Citation": "Honjo K., Reekum R.V., Verhoeff N.P.L.G. Alzheimer\u2019s disease and infection: Do infectious agents contribute to progression of Alzheimer\u2019s disease? Alzheimer. Dement. 2009;5:348\u2013360. doi: 10.1016/j.jalz.2008.12.001.", "ArticleIdList": ["10.1016/j.jalz.2008.12.001", "19560105"]}, {"Citation": "Sochocka M., Zwolinska K., Leszek J. The infectious etiology of Alzheimer\u2019s disease. Curr. Neuropharmacol. 2017;15:996\u20131009. doi: 10.2174/1570159X15666170313122937.", "ArticleIdList": ["10.2174/1570159X15666170313122937", "PMC5652018", "28294067"]}, {"Citation": "Itzhaki R.F., Lathe R., Balin B.J., Ball M.J., Bearer E.L., Braak H., Bullido M.J., Carter C., Clerici M., Cosby S.L., et al. Microbes and Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. JAD. 2016;51:979. doi: 10.3233/JAD-160152.", "ArticleIdList": ["10.3233/JAD-160152", "PMC5457904", "26967229"]}, {"Citation": "Wang L., Davis P.B., Kaelber D.C., Xu R. COVID-19 breakthrough infections and hospitalizations among vaccinated patients with dementia in the United States between December 2020 and August 2021. Alzheimers. Dement. 2023;19:421\u2013432. doi: 10.1002/alz.12669.", "ArticleIdList": ["10.1002/alz.12669", "PMC9073984", "35417628"]}, {"Citation": "Livingston G., Huntley J., Sommerlad A., Ames D., Ballard C., Banerjee S., Brayne C., Burns A., Cohen-Mansfield J., Cooper C., et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396:413\u2013446. doi: 10.1016/S0140-6736(20)30367-6.", "ArticleIdList": ["10.1016/S0140-6736(20)30367-6", "PMC7392084", "32738937"]}, {"Citation": "Wang L., Davis P.B., Volkow N.D., Berger N.A., Kaelber D.C., Xu R. Association of COVID-19 with new-onset Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 2022;89:1\u20134. doi: 10.3233/JAD-220717.", "ArticleIdList": ["10.3233/JAD-220717", "35912749"]}, {"Citation": "Anand P., Singh B. A review on cholinesterase inhibitors for Alzheimer\u2019s disease. Arch. Pharm. Res. 2013;36:375\u2013399. doi: 10.1007/s12272-013-0036-3.", "ArticleIdList": ["10.1007/s12272-013-0036-3", "23435942"]}, {"Citation": "Sharma K. Cholinesterase inhibitors as Alzheimer\u2019s therapeutics. Mol. Med. Rep. 2019;20:1479\u20131487. doi: 10.3892/mmr.2019.10374.", "ArticleIdList": ["10.3892/mmr.2019.10374", "PMC6625431", "31257471"]}, {"Citation": "Kumar A., Sidhu J., Goyal A.S.P. Alzheimer Disease. StatPearls Publishing; Treasure Island, FL, USA: 2020."}, {"Citation": "Dooley M., Lamb H.M. Donepezil: A review of its use in Alzheimer\u2019s disease. Drugs Aging. 2000;16:199\u2013226. doi: 10.2165/00002512-200016030-00005.", "ArticleIdList": ["10.2165/00002512-200016030-00005", "10803860"]}, {"Citation": "Magnuson T.M., Keller B.K., Burke W.J. Extrapyramidal side effects in a patient treated with risperidone plus donepezil. Am. J. Psychiatry. 1998;155:1458\u20131459. doi: 10.1176/ajp.155.10.1458a.", "ArticleIdList": ["10.1176/ajp.155.10.1458a", "9766783"]}, {"Citation": "Wilcock G., Howe I., Coles H., Lilienfeld S., Truyen L., Zhu Y., Bullock R., Kershaw P. A long\u2013term comparison of galantamine and donepezil in the treatment of Alzheimer\u2019s disease. Drugs Aging. 2003;20:777\u2013789. doi: 10.2165/00002512-200320100-00006.", "ArticleIdList": ["10.2165/00002512-200320100-00006", "12875613"]}, {"Citation": "Hansen R.A., Gartlehner G., Webb A.P., Morgan L.C., Moore C.G., Jonas D.E. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer\u2019s disease: A systematic review and meta-analysis. Clin. Interv. Aging. 2008;3:211\u2013225.", "ArticleIdList": ["PMC2546466", "18686744"]}, {"Citation": "Annicchiarico R., Federici A., Pettenati C., Caltagirone C. Rivastigmine in Alzheimer\u2019s disease: Cognitive function and quality of life. Ther. Clin. Risk Manag. 2007;3:1113\u20131123.", "ArticleIdList": ["PMC2387294", "18516265"]}, {"Citation": "Khoury R., Rajamanickam J., Grossberg G.T. An update on the safety of current therapies for Alzheimer\u2019s disease: Focus on rivastigmine. Ther. Adv. Drug Saf. 2018;9:171\u2013178. doi: 10.1177/2042098617750555.", "ArticleIdList": ["10.1177/2042098617750555", "PMC5810854", "29492246"]}, {"Citation": "Danysz W., Parsons C.G. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer\u2019s disease: Preclinical evidence. Int. J. Geriatr. Psychiatry. 2003;18:S23\u2013S32. doi: 10.1002/gps.938.", "ArticleIdList": ["10.1002/gps.938", "12973747"]}, {"Citation": "Malinow R. New developments on the role of NMDA receptors in Alzheimer\u2019s disease. Curr. Opin. Neurobiol. 2012;22:559\u2013563. doi: 10.1016/j.conb.2011.09.001.", "ArticleIdList": ["10.1016/j.conb.2011.09.001", "PMC3405538", "21962484"]}, {"Citation": "Scott L.J., Goa K.L. Galantamine: A review of its use in Alzheimer\u2019s disease. Drugs. 2000;60:1095\u20131122. doi: 10.2165/00003495-200060050-00008.", "ArticleIdList": ["10.2165/00003495-200060050-00008", "11129124"]}, {"Citation": "Prvulovic D., Hampel H., Pantel J. Galantamine for Alzheimer\u2019s disease. Expert. Opin. Drug Metab. Toxicol. 2010;6:345\u2013354. doi: 10.1517/17425251003592137.", "ArticleIdList": ["10.1517/17425251003592137", "20113148"]}, {"Citation": "Folch J., Busquets O., Ettcheto M., S\u00e1nchez-L\u00f3pez E., Castro-Torres R.D., Verdaguer E., Garcia M.L., Olloquequi J., Casades\u00fas G., Beas-Zarate C., et al. Memantine for the treatment of dementia: A review on its current and future applications. J. Alzheimer\u2019s D. 2018;62:1223\u20131240. doi: 10.3233/JAD-170672.", "ArticleIdList": ["10.3233/JAD-170672", "PMC5870028", "29254093"]}, {"Citation": "Rogawski M.A., Wenk G.L. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer\u2019s disease. CNS Drug Rev. 2003;9:275\u2013308. doi: 10.1111/j.1527-3458.2003.tb00254.x.", "ArticleIdList": ["10.1111/j.1527-3458.2003.tb00254.x", "PMC6741669", "14530799"]}, {"Citation": "Filho J.M.B., Medeiros K.C.P., de F\u00e1tima F.M., Batista L.M., Athayde-Filho P.F., Silva M.S., da Cunha E.V.L., Almeida J.R.G.S., Quintans-J\u00fanior L.J. Natural products inhibitors of the enzyme acetylcholinesterase. Rev. Bras. Farmacogn. 2006;16:258\u2013285. doi: 10.1590/S0102-695X2006000200021.", "ArticleIdList": ["10.1590/S0102-695X2006000200021"]}, {"Citation": "Rahman K. Studies on free radicals, antioxidants, and co\u2013factors. Clin. Interv. Aging. 2007;2:219\u2013236.", "ArticleIdList": ["PMC2684512", "18044138"]}, {"Citation": "Gauthier S., Leuzy A., Racine E., Rosa-Neto P. Diagnosis and management of Alzheimer\u2019s disease: Past, present and future ethical issues. Prog. Neurobiol. 2013;110:102\u2013113. doi: 10.1016/j.pneurobio.2013.01.003.", "ArticleIdList": ["10.1016/j.pneurobio.2013.01.003", "23578568"]}, {"Citation": "Dai Q., Borenstein A.R., Wu Y., Jackson J.C., Larson E.B. Fruit and vegetable juices and Alzheimer\u2019s disease: The Kame Project. Am. J. Med. 2006;119:751\u2013759. doi: 10.1016/j.amjmed.2006.03.045.", "ArticleIdList": ["10.1016/j.amjmed.2006.03.045", "PMC2266591", "16945610"]}, {"Citation": "Upaganlawar A.B., Wankhede N.L., Kale M.B., Umare M.D., Sehgal A., Singh S., Bhatia S., Al-Harrasi A., Najda A., Nurzy\u0144ska-Wierdak R., et al. Interweaving epilepsy and neurodegeneration: Vitamin E as a treatment approach. Biomed. Pharmacother. 2021;143:112146. doi: 10.1016/j.biopha.2021.112146.", "ArticleIdList": ["10.1016/j.biopha.2021.112146", "34507113"]}, {"Citation": "Sehgal N., Gupta A., Valli R.K., Joshi S.D., Mills J.T., Hamel E., Khanna P., Jain S.C., Thakur S.S., Ravindranath V. Withania somnifera reverses Alzheimer\u2019s disease pathology by enhancing low\u2013density lipoprotein receptor-related protein in liver. Proc. Natl. Acad. Sci. USA. 2012;109:3510\u20133515. doi: 10.1073/pnas.1112209109.", "ArticleIdList": ["10.1073/pnas.1112209109", "PMC3295277", "22308347"]}, {"Citation": "Choudhary M.I., Nawaz S.A., Lodhi M.A., Ghayur M.N., Jalil S., Riaz N., Yousuf S., Malik A., Gilani A.H. Withanolides, a new class of natural cholinesterase inhibitors with calcium antagonistic properties. Biochem. Biophys. Res. Commun. 2005;334:276\u2013287. doi: 10.1016/j.bbrc.2005.06.086.", "ArticleIdList": ["10.1016/j.bbrc.2005.06.086", "16108094"]}, {"Citation": "Pase M.P., Kean J., Sarris J., Neale C., Scholey A.B. Con Stough. The cognitive\u2013enhancing effects of Bacopa monnieri: A systematic review of randomized, controlled human clinical trials. J. Altern. Complement. Med. 2012;18:647\u2013652. doi: 10.1089/acm.2011.0367.", "ArticleIdList": ["10.1089/acm.2011.0367", "22747190"]}, {"Citation": "Mahalanobish S., Ghosh N., Sil P.C. Herbs, Shrubs, and Trees of Potential Medicinal Benefits. CRC Press; Boca Raton, FL, USA: 2022. Panax quinquefolium (American Ginseng) and Physostigma venenosum (Calabar Bean)"}, {"Citation": "Gulkari V.D., Maske D.K. Role of herbal drugs in the prevention and treatment of alzheimer\u2019s disease. World J. Pharm. Res. 2020;9:1042\u20131047."}, {"Citation": "Pereira P., De Oliveira P.A., Ardenghi P., Rotta L., Henriques J.A.P., Picada J.N. Neuropharmacological analysis of caffeic acid in rats. Basic Clin. Pharmacol. Toxicol. 2006;99:374\u2013378. doi: 10.1111/j.1742-7843.2006.pto_533.x.", "ArticleIdList": ["10.1111/j.1742-7843.2006.pto_533.x", "17076690"]}, {"Citation": "Baluchnejadmojarad T., Roghani M., Mafakheri M. Neuroprotective effect of silymarin in 6\u2013hydroxydopamine hemi\u2013parkinsonian rat: Involvement of estrogen receptors and oxidative stress. Neurosci. Lett. 2010;480:206\u2013210. doi: 10.1016/j.neulet.2010.06.038.", "ArticleIdList": ["10.1016/j.neulet.2010.06.038", "20600617"]}, {"Citation": "Rao R.V., Descamps O., John V., Bredesen D.E. Ayurvedic medicinal plants for Alzheimer\u2019s disease: A review. Alzheimer\u2019s Res. Ther. 2012;4:1\u20139. doi: 10.1186/alzrt125.", "ArticleIdList": ["10.1186/alzrt125", "PMC3506936", "22747839"]}, {"Citation": "Fernandez-Panchon M.S., Villano D., Villano Troncoso A.M., Garcia-Parrilla M.C. Antioxidant activity of phenolic compounds: From in vitro results to in vivo evidence. Crit. Rev. Food Sci. Nutr. 2008;48:649\u2013671. doi: 10.1080/10408390701761845.", "ArticleIdList": ["10.1080/10408390701761845", "18663616"]}, {"Citation": "Zheng Y., Wang C.Y., Wang S.Y., Zheng W. Effect of high-oxygen atmospheres on blueberry phenolics, anthocyanins, and antioxidant capacity. J. Agric. Food Chem. 2003;51:7162\u20137169. doi: 10.1021/jf030440k.", "ArticleIdList": ["10.1021/jf030440k", "14611188"]}, {"Citation": "Ferlemi A.V., Katsikoudi A., Kontogianni V.G., Kellici T.F., Iatrou G., Lamari F.N., Tzakos A.G., Margarity M. Rosemary tea consumption results to anxiolytic\u2013and anti\u2013depressant\u2013like behavior of adult male mice and inhibits all cerebral area and liver cholinesterase activity; phytochemical investigation and in silico studies. Chem. Biol. Interact. 2015;237:47\u201357. doi: 10.1016/j.cbi.2015.04.013.", "ArticleIdList": ["10.1016/j.cbi.2015.04.013", "25910439"]}, {"Citation": "Heinrich M., Teoh H.L. Galanthamine from snowdrop-the development of a modern drug against Alzheimer\u2019s disease from local Caucasian knowledge. J. Ethnopharmacol. 2004;92:147\u2013162. doi: 10.1016/j.jep.2004.02.012.", "ArticleIdList": ["10.1016/j.jep.2004.02.012", "15137996"]}, {"Citation": "Mishra S., Palanivelu K. The effect of curcumin (turmeric) on Alzheimer\u2019s disease: An overview. Ann. Indian Acad. Neurol. 2008;11:13. doi: 10.4103/0972-2327.40220.", "ArticleIdList": ["10.4103/0972-2327.40220", "PMC2781139", "19966973"]}, {"Citation": "Ahmed T., Gilani A.H. Therapeutic potential of turmeric in Alzheimer\u2019s disease: Curcumin or curcuminoids? Phytother Res. 2014;28:517\u2013525. doi: 10.1002/ptr.5030.", "ArticleIdList": ["10.1002/ptr.5030", "23873854"]}, {"Citation": "Brenn A., Grube M., Jedlitschky G., Fischer A., Strohmeier B., Eiden M., Keller M., Groschup M.H., Vogelgesang S. St. John\u2019s Wort Reduces Beta-Amyloid Accumulation in a Double Transgenic Alzheimer\u2019s Disease Mouse Model-Role of P-Glycoprotein. Brain Pathol. 2014;24:18\u201324. doi: 10.1111/bpa.12069.", "ArticleIdList": ["10.1111/bpa.12069", "PMC8029238", "23701205"]}, {"Citation": "Dinamarca M.C., Cerpa W., Garrido J., Hancke J.L., Inestrosa N.C. Hyperforin prevents \u03b2\u2013amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer\u2019s amyloid\u2013\u03b2\u2013deposits. Mol. Psychiatry. 2006;11:1032\u20131048. doi: 10.1038/sj.mp.4001866.", "ArticleIdList": ["10.1038/sj.mp.4001866", "16880827"]}, {"Citation": "Yusuf M., Khan M., Khan R.A., Ahmed B. Preparation, characterization, in vivo and biochemical evaluation of brain targeted piperine solid lipid nanoparticles in an experimentally induced Alzheimer\u2019s disease model. J. Drug Target. 2013;21:300\u2013311. doi: 10.3109/1061186X.2012.747529.", "ArticleIdList": ["10.3109/1061186X.2012.747529", "23231324"]}, {"Citation": "Gupta V.B., Indi S.S., Rao K.S.J. Garlic extract exhibits antiamyloidogenic activity on amyloid-beta fibrillogenesis: Relevance to Alzheimer\u2019s disease. Phytother. Res. 2009;23:111\u2013115. doi: 10.1002/ptr.2574.", "ArticleIdList": ["10.1002/ptr.2574", "18844255"]}, {"Citation": "Chauhan N.B., Sandoval J. Amelioration of early cognitive deficits by aged garlic extract in Alzheimer\u2019s transgenic mice. Phytother Res. 2007;21:629\u2013640. doi: 10.1002/ptr.2122.", "ArticleIdList": ["10.1002/ptr.2122", "17380553"]}, {"Citation": "Fehske C.J., Leuner K., M\u00fcller W.E. Ginkgo biloba extract (EGb761\u00ae) influences monoaminergic neurotransmission via inhibition of NE uptake, but not MAO activity after chronic treatment. Pharmacol. Res. 2009;60:68\u201373. doi: 10.1016/j.phrs.2009.02.012.", "ArticleIdList": ["10.1016/j.phrs.2009.02.012", "19427589"]}, {"Citation": "DeFeudis F.V., Drieu K. Stress-alleviating\u201d and \u201cvigilance-enhancing\u201d actions of Ginkgo biloba extract (EGb 761) Drug Dev. Res. 2004;62:1\u201325. doi: 10.1002/ddr.10351.", "ArticleIdList": ["10.1002/ddr.10351"]}, {"Citation": "Cioanca O., Hritcu L., Mihasan M., Hancianu M. Cognitive-enhancing and antioxidant activities of inhaled coriander volatile oil in amyloid \u03b2 (1\u201342) rat model of Alzheimer\u2019s disease. Physiol. Behav. 2013;120:193\u2013202. doi: 10.1016/j.physbeh.2013.08.006.", "ArticleIdList": ["10.1016/j.physbeh.2013.08.006", "23958472"]}, {"Citation": "Mani V., Parle M. Memory\u2013enhancing activity of Coriandrum sativum in rats. Pharmacologyonline. 2009;2:827\u2013839."}, {"Citation": "Choudhary S., Kumar P., Malik J. Plants and phytochemicals for Huntington\u2019s disease. Pharmacogn. Rev. 2013;7:81.", "ArticleIdList": ["PMC3841999", "24347915"]}, {"Citation": "Remington R., Chan A., Lepore A., Kotlya E., Shea T.B. Apple juice improved behavioral but not cognitive symptoms in moderate\u2013to\u2013late\u2013stage Alzheimer\u2019s disease in an open\u2013label pilot study. Am. J. Alzheimers Dis. Other Demen. 2010;25:367\u2013371. doi: 10.1177/1533317510363470.", "ArticleIdList": ["10.1177/1533317510363470", "20338990"]}, {"Citation": "Kim H.J., Jung S.W., Kim S.Y., Cho I.H., Kim H.C., Rhim H., Kim M., Nah S. Panax ginseng as an adjuvant treatment for Alzheimer\u2019s disease. J. Ginseng Res. 2018;42:401\u2013411. doi: 10.1016/j.jgr.2017.12.008.", "ArticleIdList": ["10.1016/j.jgr.2017.12.008", "PMC6190533", "30337800"]}, {"Citation": "Chen F., Eckman E.A., Eckman C.B. Reductions in levels of the Alzheimer\u2019s amyloid beta peptide after oral administration of ginsenosides. FASEB J. 2006;20:1269\u20131271. doi: 10.1096/fj.05-5530fje.", "ArticleIdList": ["10.1096/fj.05-5530fje", "16636099"]}, {"Citation": "Xia C.L., Tang G.H., Guo Y.Q., Xu Y.K., Huang Z.S., Yin S. Mulberry Diels\u2013Alder\u2013type adducts from Morus alba as multi\u2013targeted agents for Alzheimer\u2019s disease. Phytochemistry. 2019;157:82\u201391. doi: 10.1016/j.phytochem.2018.10.028.", "ArticleIdList": ["10.1016/j.phytochem.2018.10.028", "30390605"]}, {"Citation": "Dhanasekaran M., Holcomb L.A., Hitt A.R., Tharakan B., Porter J.W., Young K.A., Manyam B.V. Centella asiatica extract selectively decreases amyloid \u03b2 levels in hippocampus of alzheimer\u2019s disease animal model. Phytother. Res. 2009;23:14\u201319. doi: 10.1002/ptr.2405.", "ArticleIdList": ["10.1002/ptr.2405", "19048607"]}, {"Citation": "Jia H., Jiang Y., Ruan Y., Zhang Y., Ma X., Zhang J., Beyreuther K., Tu P., Zhang D. Tenuigenin treatment decreases secretion of the Alzheimer\u2019s disease amyloid \u03b2\u2013protein in cultured cells. Neurosci. Lett. 2004;367:123\u2013128. doi: 10.1016/j.neulet.2004.05.093.", "ArticleIdList": ["10.1016/j.neulet.2004.05.093", "15308312"]}, {"Citation": "Park C.H., Choi S.H., Koo J.W., Seo J.H., Kim H.S., Jeong S.J., Suh Y.H. Novel cognitive improving and neuroprotective activities of Polygala tenuifolia Willdenow extract, BT-11. J. Neurosci. Res. 2002;70:484\u2013492. doi: 10.1002/jnr.10429.", "ArticleIdList": ["10.1002/jnr.10429", "12391609"]}, {"Citation": "Elameen A., Dragland S., Klemsdal S.S. Bioactive compounds produced by clones of Rhodiola rosea maintained in the Norwegian germplasm collection. Pharmazie. 2010;65:618\u2013623.", "ArticleIdList": ["20824964"]}, {"Citation": "Qu Z.Q., Zhou Y., Zeng Y.S., Li Y., Chung P. Pretreatment with Rhodiola rosea extract reduces cognitive impairment induced by intracerebroventricular streptozotocin in rats: Implication of anti\u2013oxidative and neuroprotective effects. Biomed. Environ. Sci. 2009;22:318\u2013326. doi: 10.1016/S0895-3988(09)60062-3.", "ArticleIdList": ["10.1016/S0895-3988(09)60062-3", "19950527"]}, {"Citation": "Kennedy D.O., Scholey A.B., Tildesley N.T.J., Perry E.K., Wesnes K.A. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm) Pharmacol. Biochem. Behav. 2002;72:953\u2013964. doi: 10.1016/S0091-3057(02)00777-3.", "ArticleIdList": ["10.1016/S0091-3057(02)00777-3", "12062586"]}, {"Citation": "Nyakas C., Klara F., Robert S., Keijser J.N., Luiten P.G.M., Szombathelyi Z., Tihanyi K. Neuroprotective effects of vinpocetine and its major metabolite cis-apovincaminic acid on NMDA-induced neurotoxicity in a rat entorhinal cortex lesion model. CNS Neuros. Ther. 2009;15:89\u201399. doi: 10.1111/j.1755-5949.2009.00078.x.", "ArticleIdList": ["10.1111/j.1755-5949.2009.00078.x", "PMC6494022", "19492990"]}, {"Citation": "Rezai-Zadeh K., Arendash G.W., Hou H., Fernandez F., Jensen M., Runfeldt M., Shytle R.D., Tan J. Green tea epigallocatechin\u20133\u2013gallate (EGCG) reduces \u03b2\u2013amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res. 2008;1214:177\u2013187. doi: 10.1016/j.brainres.2008.02.107.", "ArticleIdList": ["10.1016/j.brainres.2008.02.107", "18457818"]}, {"Citation": "Biasibetti R., Tramontina A.C., Costa A.P., Dutra M.F., Quincozes-Santos A., Patr\u00edcia N., Bernardi C.L., Wartchow K.M., Lunardi P.S., Gon\u00e7alves C.A. Green tea (\u2212) epigallocatechin\u20133\u2013gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin\u2013induced model of dementia. Behav. Brain Res. 2013;236:186\u2013193. doi: 10.1016/j.bbr.2012.08.039.", "ArticleIdList": ["10.1016/j.bbr.2012.08.039", "22964138"]}, {"Citation": "Sun A.Y., Wang Q., Simonyi A., Sun G.Y. Botanical phenolics and brain health. Neuromol. Med. 2008;10:259\u2013274. doi: 10.1007/s12017-008-8052-z.", "ArticleIdList": ["10.1007/s12017-008-8052-z", "PMC2682367", "19191039"]}, {"Citation": "Eubanks L.M., Rogers C.J., Beuscher IV A.E., Koob G.F., Olson A.J., Dickerson T.J., Janda K.D. A molecular link between the active component of marijuana and Alzheimer\u2019s disease pathology. Mol. Pharm. 2006;3:773\u2013777. doi: 10.1021/mp060066m.", "ArticleIdList": ["10.1021/mp060066m", "PMC2562334", "17140265"]}, {"Citation": "Bazoti F.N., Bergquist J., Markides K.E., Tsarbopoulos A. Noncovalent interaction between amyloid\u2013\u03b2\u2013peptide (1\u201340) and oleuropein studied by electrospray ionization mass spectrometry. J. Am. Soc. Mass Spectrom. 2006;17:568\u2013575. doi: 10.1016/j.jasms.2005.11.016.", "ArticleIdList": ["10.1016/j.jasms.2005.11.016", "16503156"]}, {"Citation": "Singhal A.K., Naithani Vijay N., Bangar O.P. Medicinal plants with a potential to treat Alzheimer and associated symptoms. Int. J. Nutr. Pharmacol. Neurol. Dis. 2012;2:84. doi: 10.4103/2231-0738.95927.", "ArticleIdList": ["10.4103/2231-0738.95927"]}, {"Citation": "Ma X., Gang D.R. In vitro production of huperzine A, a promising drug candidate for Alzheimer\u2019s disease. Phytochemistry. 2008;69:2022\u20132028. doi: 10.1016/j.phytochem.2008.04.017.", "ArticleIdList": ["10.1016/j.phytochem.2008.04.017", "18538805"]}, {"Citation": "Hartman R.E., Shah A., Fagan A.M., Schwetye K.E., Parsadanian M., Schulman R.N., Finn M.B., Holtzman D.M. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer\u2019s disease. Neurobiol. Dis. 2006;24:506\u2013515. doi: 10.1016/j.nbd.2006.08.006.", "ArticleIdList": ["10.1016/j.nbd.2006.08.006", "17010630"]}, {"Citation": "Kwak H.M., Jeon S.Y., Sohng B.H., Kim J.G., Lee J.M., Lee K.B., Jeong H.H., Hur J.M., Kang Y.H., Song K.S. \u03b2\u2013Secretase (BACE1) inhibitors from pomegranate (Punica granatum) husk. Arch. Pharm. Res. 2005;28:1328\u20131332. doi: 10.1007/BF02977896.", "ArticleIdList": ["10.1007/BF02977896", "16392663"]}, {"Citation": "da Silva A.L., Piato \u00c2.L., Ferreira J.G., Martins B.S., Nunes D.S., Elisabetsky E. Promnesic effects of Ptychopetalum olacoides in aversive and non\u2013aversive learning paradigms. J. Ethnopharmacol. 2007;109:449\u2013457. doi: 10.1016/j.jep.2006.08.022.", "ArticleIdList": ["10.1016/j.jep.2006.08.022", "17023132"]}, {"Citation": "Figueir\u00f3 M., Ilha J., Linck V.M., Herrmann A.P., Nardin P., Menezes C.B., Achaval M., Gon\u00e7alves C.A., Porci\u00fancula L.O., Nunes D.S., et al. The Amazonian herbal Marapuama attenuates cognitive impairment and neuroglial degeneration in a mouse Alzheimer model. Phytomedicine. 2011;18:327\u2013333. doi: 10.1016/j.phymed.2010.07.013.", "ArticleIdList": ["10.1016/j.phymed.2010.07.013", "20739160"]}, {"Citation": "Arantes S., Pi\u00e7arra A., Candeias F., Teixeira D., Caldeira A.T., Martins M.R. Antioxidant activity and cholinesterase inhibition studies of four flavouring herbs from Alentejo. Nat. Prod. Res. 2017;31:2183\u20132187. doi: 10.1080/14786419.2017.1278598.", "ArticleIdList": ["10.1080/14786419.2017.1278598", "28076987"]}, {"Citation": "Essa M.M., Vijayan R.K., Castellano-Gonzalez G., Memon M.A., Braidy N., Guillemin G.J. Neuroprotective effect of natural products against Alzheimer\u2019s disease. Neurochem. Res. 2012;37:1829\u20131842. doi: 10.1007/s11064-012-0799-9.", "ArticleIdList": ["10.1007/s11064-012-0799-9", "22614926"]}, {"Citation": "Akhondzadeh S., Sabet M.S., Harirchian M.H., Togha M., Cheraghmakani H., Razeghi S., Hejazi S.S., Yousefi M.H., Alimardani R., Jamshidi A., et al. A 22\u2013week, multicenter, randomized, double\u2013blind controlled trial of Crocus sativus in the treatment of mild\u2013to\u2013moderate Alzheimer\u2019s disease. Psychopharmacology. 2010;207:637\u2013643. doi: 10.1007/s00213-009-1706-1.", "ArticleIdList": ["10.1007/s00213-009-1706-1", "19838862"]}, {"Citation": "Perry N.S.L., Bollen C., Perry E.K., Ballard C. Salvia for dementia therapy: Review of pharmacological activity and pilot tolerability clinical trial. Pharmacol. Biochem. Behav. 2003;75:651\u2013659. doi: 10.1016/S0091-3057(03)00108-4.", "ArticleIdList": ["10.1016/S0091-3057(03)00108-4", "12895683"]}, {"Citation": "de Oliveira T.S., Thomaz D.V., Neri H.F.S., Cerqueira L.B., Garcia L.F., Gil H.P.V., Pontarolo R., Campos F.R., Costa E.A., Santos F.C.A.D., et al. Neuroprotective effect of Caryocar brasiliense Camb. leaves are associated with anticholinesterase and antioxidant properties. Oxid. Med. Cell. Longev. 2018;2018:9842908. doi: 10.1155/2018/9842908.", "ArticleIdList": ["10.1155/2018/9842908", "PMC6215548", "30420910"]}, {"Citation": "Fernando W.M.A.D.B., Martins I.J., Goozee K.G., Brennan C.S., Jayasena V., Martins R.N. The role of dietary coconut for the prevention and treatment of Alzheimer\u2019s disease: Potential mechanisms of action. Br. J. Nutr. 2015;114:1\u201314. doi: 10.1017/S0007114515001452.", "ArticleIdList": ["10.1017/S0007114515001452", "25997382"]}, {"Citation": "Hsieh C.L., Chen M.F., Li T.C., Li S.C., Tang N.Y., Hsieh C.T., Pon C.Z., Lin J.G. Anticonvulsant effect of Uncaria rhynchophylla (Miq) Jack. in rats with kainic acid\u2013induced epileptic seizure. Am. J. Chin. Med. 1999;27:257\u2013264. doi: 10.1142/S0192415X9900029X.", "ArticleIdList": ["10.1142/S0192415X9900029X", "10467459"]}, {"Citation": "Parihar M.S., Chaudhary M., Shetty R., Hemnani T. Susceptibility of hippocampus and cerebral cortex to oxidative damage in streptozotocin treated mice: Prevention by extracts of Withania somnifera and Aloe vera. J. Clin. Neurosci. 2004;11:397\u2013402. doi: 10.1016/j.jocn.2003.09.008.", "ArticleIdList": ["10.1016/j.jocn.2003.09.008", "15080956"]}, {"Citation": "Zhao Z., He X., Han W., Chen X., Liu P., Zhao X., Wang X., Zhang L., Wu S., Zheng X. Genus Tetradium L.: A comprehensive review on traditional uses, phytochemistry, and pharmacological activities. J Ethnopharmacol. 2019;231:337\u2013354. doi: 10.1016/j.jep.2018.11.035.", "ArticleIdList": ["10.1016/j.jep.2018.11.035", "30472402"]}, {"Citation": "Ekong M.B., Ekpo M.M., Akpanyung E.O., Nwaokonko D.U. Neuroprotective effect of Moringa oleifera leaf extract on aluminium\u2013induced temporal cortical degeneration. Metab. Brain Dis. 2017;32:1437\u20131447. doi: 10.1007/s11011-017-0011-7.", "ArticleIdList": ["10.1007/s11011-017-0011-7", "28397152"]}, {"Citation": "Chauhan N., Wang K.C., Wegiel J., Malik M.N. Walnut extract inhibits the fibrillization of amyloid beta\u2013protein, and also defibrillizes its preformed fibrils. Curr. Alzheimer Res. 2004;1:183\u2013188. doi: 10.2174/1567205043332144.", "ArticleIdList": ["10.2174/1567205043332144", "15975066"]}, {"Citation": "Muthaiyah B., Essa M.M., Chauhan V., Chauhan A. Protective effects of walnut extract against amyloid beta peptide\u2013induced cell death and oxidative stress in PC12 cells. Neurochem. Res. 2011;36:2096\u20132103. doi: 10.1007/s11064-011-0533-z.", "ArticleIdList": ["10.1007/s11064-011-0533-z", "PMC3183245", "21706234"]}, {"Citation": "George R.C., Lew J., Graves D.J. Interaction of cinnamaldehyde and epicatechin with tau: Implications of beneficial effects in modulating Alzheimer\u2019s disease pathogenesis. J. Alzheimer\u2019s Dis. 2013;36:21\u201340. doi: 10.3233/JAD-122113.", "ArticleIdList": ["10.3233/JAD-122113", "23531502"]}, {"Citation": "Uddin M.S., Mamun A.A., Hossain M.S., Ashaduzzaman M., Noor M.A.A.N., Hossain M.S., Uddin M.J., Sarker J., Asaduzzaman M. Neuroprotective effect of Phyllanthus acidus L. on learning and memory impairment in scopolamine\u2013induced animal model of dementia and oxidative stress: Natural wonder for regulating the development and progression of Alzheimer\u2019s disease. Adv. Alzheimer\u2019s Dis. 2016;5:53\u201372. doi: 10.4236/aad.2016.52005.", "ArticleIdList": ["10.4236/aad.2016.52005"]}, {"Citation": "Akram M., Nawaz A. Effects of medicinal plants on Alzheimer\u2019s disease and memory deficits. Neural Regen Res. 2017;12:660. doi: 10.4103/1673-5374.205108.", "ArticleIdList": ["10.4103/1673-5374.205108", "PMC5436367", "28553349"]}, {"Citation": "Rasool I.F., Aziz A., Khalid W., Koraqi H., Siddiqui S.A., Al-Farga A., Lai W.F., Ali A. Industrial Application and Health Prospective of Fig (Ficus carica) By\u2013Products. Molecules. 2023;28:960. doi: 10.3390/molecules28030960.", "ArticleIdList": ["10.3390/molecules28030960", "PMC9919570", "36770628"]}, {"Citation": "Saxena D., Sharma U., Gupta S., Mahajan S. Pumpkin seeds as a power house of nutrition: A Review. Indian J. Nutr. Diet. 2022;59:379\u2013387. doi: 10.21048/IJND.2022.59.3.28957.", "ArticleIdList": ["10.21048/IJND.2022.59.3.28957"]}, {"Citation": "Parihar M.S., Hemnani T. Phenolic antioxidants attenuate hippocampal neuronal cell damage against kainic acid induced excitotoxicity. J. Biosci. 2003;28:121\u2013128. doi: 10.1007/BF02970142.", "ArticleIdList": ["10.1007/BF02970142", "12682435"]}, {"Citation": "Sethiya N.K., Nahata A., Mishra S.H.M., Dixit V.K. An update on Shankhpushpi, a cognition\u2013boosting Ayurvedic medicine. Chin. J. Integr. Med. 2009;7:1001\u20131022. doi: 10.3736/jcim20091101.", "ArticleIdList": ["10.3736/jcim20091101", "19912732"]}, {"Citation": "Agarwal P., Holland T.M., Wang Y., Bennett D.A., Morris M.C. Association of strawberries and anthocyanidin intake with Alzheimer\u2019s dementia risk. Nutrients. 2019;11:3060. doi: 10.3390/nu11123060.", "ArticleIdList": ["10.3390/nu11123060", "PMC6950087", "31847371"]}, {"Citation": "Kaur N., Sarkar B., Gill I., Kaur S., Mittal S., Dhiman M., Padala P.R., Polo R.P., Mantha A.K. Neuroprotective Effects of Phytochemicals in Neurological Disorders. Wiley Online Library; Hoboken, NJ, USA: 2017. Indian herbs and their therapeutic potential against Alzheimer\u2019s disease and other neurological disorders; pp. 79\u2013112.", "ArticleIdList": ["10.1002/9781119155195.ch4"]}, {"Citation": "Ravikumar C. Therapeutic potential of Brassica oleracea (broccoli)\u2013a review. Int. J. Drug Dev. Res. 2015;7:9\u201310."}, {"Citation": "Jiraungkoorskul W. Review of neuro\u2013nutrition used as anti\u2013alzheimer plant, spinach, Spinacia oleracea. Pharmacogn. Rev. 2016;10:105\u2013108. doi: 10.4103/0973-7847.194040.", "ArticleIdList": ["10.4103/0973-7847.194040", "PMC5214553", "28082792"]}, {"Citation": "Subash S., Essa M.M., Braidy N., Awlad-Thani K., Vaishnav R., Al-Adawi S., Al-Asmi A., Guillemin G.J. Diet rich in date palm fruits improves memory, learning and reduces beta amyloid in transgenic mouse model of Alzheimer\u2019s disease. J. Ayurveda Integr. Med. 2015;6:111\u2013120.", "ArticleIdList": ["PMC4484046", "26167001"]}, {"Citation": "Yang Y., Liang X., Jin P., Li N., Zhang Q., Yan W., Zhang H., Sun J. Screening and determination for potential acetylcholinesterase inhibitory constituents from ginseng stem\u2013leaf saponins using ultrafiltration (UF)-LC-ESI-MS2. Phytochem. Anal. 2019;30:26\u201333. doi: 10.1002/pca.2787.", "ArticleIdList": ["10.1002/pca.2787", "30159954"]}, {"Citation": "Choi D.Y., Lee Y.J., Hong J.T., Lee H.J. Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer\u2019s disease. Brain Res. Bull. 2012;87:144\u2013153. doi: 10.1016/j.brainresbull.2011.11.014.", "ArticleIdList": ["10.1016/j.brainresbull.2011.11.014", "22155297"]}, {"Citation": "Prachayasittikul V., Prachayasittikul S., Ruchirawat S., Prachayasittikul V. 8\u2013Hydroxyquinolines: A review of their metal chelating properties and medicinal applications. Drug Des. Devel. Ther. 2013;7:1157\u20131178. doi: 10.2147/DDDT.S49763.", "ArticleIdList": ["10.2147/DDDT.S49763", "PMC3793592", "24115839"]}, {"Citation": "Moon J., Choi S.H., Shim J.Y., Park H.J., Oh M.J., Kim M., Nah S.Y. Gintonin administration is safe and potentially beneficial in cognitively impaired elderly. Alzheimer Dis. Assoc. Disord. 2018;32:85\u201387. doi: 10.1097/WAD.0000000000000213.", "ArticleIdList": ["10.1097/WAD.0000000000000213", "29028648"]}, {"Citation": "Soumyanath A., Zhong Y.P., Henson E., Wadsworth T., Bishop J., Gold B.G., Quinn J.F. Centella asiatica extract improves behavioral deficits in a mouse model of Alzheimer\u2019s disease: Investigation of a possible mechanism of action. Int. J. Alzheimers Dis. 2012;2012:381974.", "ArticleIdList": ["PMC3296229", "22506133"]}, {"Citation": "Gupta Y.K., Kumar M.H.V., Srivastava A.K. Effect of Centella asiatica on pentylenetetrazole\u2013induced kindling, cognition and oxidative stress in rats. Pharmacol. Biochem. Behav. 2003;74:579\u2013585. doi: 10.1016/S0091-3057(02)01044-4.", "ArticleIdList": ["10.1016/S0091-3057(02)01044-4", "12543222"]}, {"Citation": "Matthews D.G., Caruso M., Murchison C.F., Zhu J.Y., Wright K.M., Harris C.J., Gray N.E., Quinn J.F., Soumyanath A. Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice. Antioxidants. 2019;8:630. doi: 10.3390/antiox8120630.", "ArticleIdList": ["10.3390/antiox8120630", "PMC6943631", "31817977"]}, {"Citation": "Barbosa N.R., Pittella F., Gattaz F. Centella asiatica water extract inhibits iPLA2 and cPLA2 activities in rat cerebellum. Phytomedicine. 2008;15:896\u2013900. doi: 10.1016/j.phymed.2008.02.007.", "ArticleIdList": ["10.1016/j.phymed.2008.02.007", "18455381"]}, {"Citation": "Mal\u00edk M., Tlusto\u0161 P. Nootropic Herbs, Shrubs, and Trees as Potential Cognitive Enhancers. Plants. 2023;12:1364. doi: 10.3390/plants12061364.", "ArticleIdList": ["10.3390/plants12061364", "PMC10056569", "36987052"]}, {"Citation": "Kudolo G.B., Dorsey S., Blodgett J. Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and Type 2 diabetic subjects. Thromb. Res. 2002;108:151\u2013160. doi: 10.1016/S0049-3848(02)00394-8.", "ArticleIdList": ["10.1016/S0049-3848(02)00394-8", "12590952"]}, {"Citation": "Barbalho S.M., Direito R., Laurindo L.F., Marton L.T., Guiguer E.L., Goulart R.A., Tofano R.J., Carvalho A.C.A., Flato U.A.P., Tofano V.A.C., et al. Ginkgo biloba in the aging process: A narrative review. Antioxidants. 2022;11:525. doi: 10.3390/antiox11030525.", "ArticleIdList": ["10.3390/antiox11030525", "PMC8944638", "35326176"]}, {"Citation": "Li D., Ma J., Wei B., Gao S., Lang Y., Wan X. Effectiveness and safety of ginkgo biloba preparations in the treatment of Alzheimer\u2019s disease: A systematic review and meta-analysis. Front. Aging Neurosci. 2023;15:1124710. doi: 10.3389/fnagi.2023.1124710.", "ArticleIdList": ["10.3389/fnagi.2023.1124710", "PMC10028084", "36960422"]}, {"Citation": "Park S.Y., Kim D.S.H.L. Discovery of natural products from Curcuma l onga that protect cells from beta\u2013amyloid insult: A drug discovery effort against Alzheimer\u2019s disease. J. Nat. Prod. 2002;65:1227\u20131231. doi: 10.1021/np010039x.", "ArticleIdList": ["10.1021/np010039x", "12350137"]}, {"Citation": "Garcia-Alloza M., Borrelli L.A., Rozkalne A., Hyman B.T., Bacskai B.J. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J. Neurochem. 2007;102:1095\u20131104. doi: 10.1111/j.1471-4159.2007.04613.x.", "ArticleIdList": ["10.1111/j.1471-4159.2007.04613.x", "17472706"]}, {"Citation": "Kim G.Y., Kim K.H., Lee S.H., Yoon M.S., Lee H.J., Moon D.O., Lee C.M., Ahn S.C., Park Y.C., Park Y.M. Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF\u2013\u03baB as potential targets. J. Immunol. 2005;174:8116\u20138124. doi: 10.4049/jimmunol.174.12.8116.", "ArticleIdList": ["10.4049/jimmunol.174.12.8116", "15944320"]}, {"Citation": "Sadhu A., Upadhyay P., Agrawal A., Ilango K., Karmakar D., Singh G.P.I., Dubey G.P. Management of cognitive determinants in senile dementia of Alzheimer\u2019s type: Therapeutic potential of a novel polyherbal drug product. Clin. Drug Investig. 2014;34:857\u2013869. doi: 10.1007/s40261-014-0235-9.", "ArticleIdList": ["10.1007/s40261-014-0235-9", "25316430"]}, {"Citation": "Limpeanchob N., Jaipan S., Rattanakaruna S., Phrompittayarat W., Ingkaninan K. Neuroprotective effect of Bacopa monnieri on beta\u2013amyloid\u2013induced cell death in primary cortical culture. J. Ethnopharmacol. 2008;120:112\u2013117. doi: 10.1016/j.jep.2008.07.039.", "ArticleIdList": ["10.1016/j.jep.2008.07.039", "18755259"]}, {"Citation": "Chaudhari K.S., Tiwari N.R., Tiwari R.R., Sharma R.S. Neurocognitive effect of nootropic drug Brahmi (Bacopa monnieri) in Alzheimer\u2019s disease. Ann. Neurosci. 2017;24:111\u2013122. doi: 10.1159/000475900.", "ArticleIdList": ["10.1159/000475900", "PMC5448442", "28588366"]}, {"Citation": "Bhattacharya S.K., Bhattacharya A., Kumar A., Ghosal S. Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytother. Res. 2000;14:174\u2013179. doi: 10.1002/(SICI)1099-1573(200005)14:3<174::AID-PTR624>3.0.CO;2-O.", "ArticleIdList": ["10.1002/(SICI)1099-1573(200005)14:3<174::AID-PTR624>3.0.CO;2-O", "10815010"]}, {"Citation": "Peng J., Zheng T.T., Li X., Liang Y., Wang L.J., Huang Y.C., Xiao H.T. Plant\u2013derived alkaloids: The promising disease\u2013modifying agents for inflammatory bowel disease. Front. Pharmacol. 2019;10:351. doi: 10.3389/fphar.2019.00351.", "ArticleIdList": ["10.3389/fphar.2019.00351", "PMC6473079", "31031622"]}, {"Citation": "Morgan A., Stevens J. Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial. J. Altern. Complement. Med. 2010;16:753\u2013759. doi: 10.1089/acm.2009.0342.", "ArticleIdList": ["10.1089/acm.2009.0342", "20590480"]}, {"Citation": "Mirjalili M.H., Moyano E., Bonfill M., Cusido R.M., Palaz\u00f3n J. Steroidal lactones from Withania somnifera, an ancient plant for novel medicine. Molecules. 2009;14:2373\u20132393. doi: 10.3390/molecules14072373.", "ArticleIdList": ["10.3390/molecules14072373", "PMC6255378", "19633611"]}, {"Citation": "Xu Q., Zhang L., Yu J., Wageh S., Al-Ghamdi A.A., Jaroniec M. Direct Z\u2013scheme photocatalysts: Principles, synthesis, and applications. Mater. Today. 2018;21:1042\u20131063. doi: 10.1016/j.mattod.2018.04.008.", "ArticleIdList": ["10.1016/j.mattod.2018.04.008"]}, {"Citation": "Singh N., Bhalla M., de Jager P., Gilca M. An overview on ashwagandha: A Rasayana (rejuvenator) of Ayurveda. Afr. J. Tradit. Complement. Altern. Med. 2011;8:208\u2013213. doi: 10.4314/ajtcam.v8i5S.9.", "ArticleIdList": ["10.4314/ajtcam.v8i5S.9", "PMC3252722", "22754076"]}, {"Citation": "Saini D., Srivastava M., Vaid S., Kesharwani V. Therapeutic effects of Withania somnifera: An Overview with Special Focus on Alzheimer\u2019s Disease and Infertility among Youth. Nutraceuticals Funct. Foods Immunomodulators. 2023:331\u2013348. doi: 10.1007/978-981-19-2507-8_14.", "ArticleIdList": ["10.1007/978-981-19-2507-8_14"]}, {"Citation": "Choudhary D., Bhattacharyya S., Bose S. Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions. J. Diet. Suppl. 2017;14:599\u2013612. doi: 10.1080/19390211.2017.1284970.", "ArticleIdList": ["10.1080/19390211.2017.1284970", "28471731"]}, {"Citation": "Ghadrdoost B., Vafaei A.A., Rashidy-Pour A., Hajisoltani R., Bandegi A.R., Motamedi F., Haghighi S., Sameni H.R., Pahlvan S. Protective effects of saffron extract and its active constituent crocin against oxidative stress and spatial learning and memory deficits induced by chronic stress in rats. Eur. J. Pharmacol. 2011;667:222\u2013229. doi: 10.1016/j.ejphar.2011.05.012.", "ArticleIdList": ["10.1016/j.ejphar.2011.05.012", "21616066"]}, {"Citation": "Ghaffari S., Hatami H., Dehghan G. Saffron ethanolic extract attenuates oxidative stress, spatial learning, and memory impairments induced by local injection of ethidium bromide. Res. Pharm. Sci. 2015;10:222.", "ArticleIdList": ["PMC4621629", "26600849"]}, {"Citation": "Papandreou M.A., Kanakis C.D., Polissiou M.G., Efthimiopoulos S., Cordopatis P., Margarity M., Lamari F.N. Inhibitory activity on amyloid\u2013\u03b2 aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. J. Agric. Food Chem. 2006;54:8762\u20138768. doi: 10.1021/jf061932a.", "ArticleIdList": ["10.1021/jf061932a", "17090119"]}, {"Citation": "Oboh G., Ademiluyi A.O., Akinyemi A.J. Inhibition of acetylcholinesterase activities and some pro\u2013oxidant induced lipid peroxidation in rat brain by two varieties of ginger (Zingiber officinale) Exp. Toxicol. Pathol. 2012;64:315\u2013319. doi: 10.1016/j.etp.2010.09.004.", "ArticleIdList": ["10.1016/j.etp.2010.09.004", "20952170"]}, {"Citation": "Zeng G.F., Zhang Z.Y., Lu L., Xiao D.Q., Zong S.H., He J.M. Protective effects of ginger root extract on Alzheimer disease-induced behavioral dysfunction in rats. Rejuvenation Res. 2013;16:124\u2013133. doi: 10.1089/rej.2012.1389.", "ArticleIdList": ["10.1089/rej.2012.1389", "23374025"]}, {"Citation": "Na J.Y., Song K., Lee J.W., Kim S., Kwon J. 6-Shogaol has anti-amyloidogenic activity and ameliorates Alzheimer\u2019s disease via CysLT1R-mediated inhibition of cathepsin B. Biochem. Biophys. Res. Commun. 2016;477:96\u2013102. doi: 10.1016/j.bbrc.2016.06.026.", "ArticleIdList": ["10.1016/j.bbrc.2016.06.026", "27286707"]}, {"Citation": "Machado D.G., Cunha M.P., Neis V.B., Balen G.O., Colla A.R., Grando J., Brocardo P.S., Bettio L.E.B., Dalmarco J.B., Rial D., et al. Rosmarinus officinalis L. hydroalcoholic extract, similar to fluoxetine, reverses depressive\u2013like behavior without altering learning deficit in olfactory bulbectomized mice. J. Ethnopharmacol. 2012;143:158\u2013169. doi: 10.1016/j.jep.2012.06.017.", "ArticleIdList": ["10.1016/j.jep.2012.06.017", "22721880"]}, {"Citation": "Zhang D., Lee B., Nutter A., Song P., Dolatabadi N., Parker J., Sanz-Blasco S., Newmeyer T., Ambasudhan R., McKercher S.R., et al. Protection from cyanide-induced brain injury by the Nrf2 transcriptional activator carnosic acid. J. Neurochem. 2015;133:898\u2013908. doi: 10.1111/jnc.13074.", "ArticleIdList": ["10.1111/jnc.13074", "PMC4465065", "25692407"]}, {"Citation": "Lian K.C., Chuang J.J., Hsieh C.W., Wung B.S., Huang G.D., Jian T.Y., Sun Y.W. Dual mechanisms of NF\u2013\u03baB inhibition in carnosol\u2013treated endothelial cells. Toxicol. Appl. Pharmacol. 2010;245:21\u201335. doi: 10.1016/j.taap.2010.01.003.", "ArticleIdList": ["10.1016/j.taap.2010.01.003", "20116392"]}, {"Citation": "Foresti R., Bains S.K., Pitchumony T.S., Br\u00e1s L.E.C., Drago F., Dubois-Rand\u00e9 J.L., Bucolo C., Motterlini R. Small molecule activators of the Nrf2\u2013HO\u20131 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells. Pharmacol. Res. 2013;76:132\u2013148. doi: 10.1016/j.phrs.2013.07.010.", "ArticleIdList": ["10.1016/j.phrs.2013.07.010", "23942037"]}, {"Citation": "Nematolahi P., Mehrabani M., Karami-Mohajeri S., Dabaghzadeh F. Effects of Rosmarinus officinalis L. on memory performance, anxiety, depression, and sleep quality in university students: A randomized clinical trial. Complement. Ther. Clin. Pract. 2018;30:24\u201328. doi: 10.1016/j.ctcp.2017.11.004.", "ArticleIdList": ["10.1016/j.ctcp.2017.11.004", "29389474"]}, {"Citation": "Manickavasagan A., Essa M.M., Ethirajan S., editors. Dates: Production, Processing, Food, and Medicinal Values. CRC Press; Boca Raton, FL, USA: 2012."}, {"Citation": "Daoud R.T.E. Ph.D. Thesis. An-Najah National University; Nablus, Palestine: 2008. Studies on Folkloric Medicinal Plants Used by Palestinians in the Qalqilia district."}, {"Citation": "Pujari R.R., Vyawahare N.S., Thakurdesai P.A. Neuroprotective and antioxidant role of Phoenix dactylifera in permanent bilateral common carotid occlusion in rats. J. Acute Dis. 2014;3:104\u2013114. doi: 10.1016/S2221-6189(14)60026-3.", "ArticleIdList": ["10.1016/S2221-6189(14)60026-3"]}, {"Citation": "Subash S., Essa M.M., Al-Asmi A., Al-Adawi S., Vaishnav R., Guillemin G.J. Effect of dietary supplementation of dates in Alzheimer\u2019s disease APPsw/2576 transgenic mice on oxidative stress and antioxidant status. Nutr. Neurosci. 2015;18:281\u2013288. doi: 10.1179/1476830514Y.0000000134.", "ArticleIdList": ["10.1179/1476830514Y.0000000134", "24954036"]}, {"Citation": "Richard D.M., Dawes M.A., Mathias C.W., Acheson A., Hill-Kapturczak N., Dougherty D.M. L\u2013tryptophan: Basic metabolic functions, behavioral research and therapeutic indications. Int. J. Tryptophan Res. 2009;2:45\u201360. doi: 10.4137/IJTR.S2129.", "ArticleIdList": ["10.4137/IJTR.S2129", "PMC2908021", "20651948"]}, {"Citation": "Zeisel S.H. Nutritional importance of choline for brain development. J. Am. Coll. Nutr. 2004;23:621S\u2013626S. doi: 10.1080/07315724.2004.10719433.", "ArticleIdList": ["10.1080/07315724.2004.10719433", "15640516"]}, {"Citation": "Jawaid T., Shakya A.K., Siddiqui H.H., Kamal M. Evaluation of Cucurbita maxima extract against scopolamine\u2013induced amnesia in rats: Implication of tumour necrosis factor alpha. Z. Naturforsch. C J. Biosci. 2014;69:407\u2013417. doi: 10.5560/znc.2014-0003.", "ArticleIdList": ["10.5560/znc.2014-0003", "25711042"]}, {"Citation": "Ho S.C., Su M.S. Evaluating the anti\u2013neuroinflammatory capacity of raw and steamed garlic as well as five organosulfur compounds. Molecules. 2014;19:17697\u201317714. doi: 10.3390/molecules191117697.", "ArticleIdList": ["10.3390/molecules191117697", "PMC6271092", "25365295"]}, {"Citation": "Lin G.H., Lee Y.J., Choi D.Y., Han S.B., Jung J.K., Hwang B.Y., Moon D.C., Kim Y., Lee M.K., Oh K.-W., et al. Anti\u2013amyloidogenic effect of thiacremonone through anti\u2013inflamation in vitro and in vivo models. J. Alzheimer\u2019s Dis. 2012;29:659\u2013676. doi: 10.3233/JAD-2012-111709.", "ArticleIdList": ["10.3233/JAD-2012-111709", "22297647"]}, {"Citation": "Ha G.T., Wong R.K., Zhang Y. Huperzine a as potential treatment of Alzheimer\u2019s disease: An assessment on chemistry, pharmacology, and clinical studies. Chem. Biodivers. 2011;8:1189\u20131204. doi: 10.1002/cbdv.201000269.", "ArticleIdList": ["10.1002/cbdv.201000269", "21766442"]}, {"Citation": "Gordon R.K., Nigam S.V., Weitz J.A., Dave J.R., Doctor B.P., Ved H.S. The NMDA receptor ion channel: A site for binding of Huperzine A. J. Appl. Toxicol. 2001;21:S47\u2013S51. doi: 10.1002/jat.805.", "ArticleIdList": ["10.1002/jat.805", "11920920"]}, {"Citation": "Wang C.Y., Zheng W., Wang T., Xie J.W., Wang S.L., Zhao B.L., Teng W.P., Wang Z.Y. Huperzine A activates Wnt/\u03b2\u2013catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model. Neuropsychopharmacology. 2011;36:1073\u20131089. doi: 10.1038/npp.2010.245.", "ArticleIdList": ["10.1038/npp.2010.245", "PMC3077275", "21289607"]}, {"Citation": "Smith A., Giunta B., Bickford P.C., Fountain M., Tan J., Shytle R.D. Nanolipidic particles improve the bioavailability and \u03b1\u2013secretase inducing ability of epigallocatechin\u20133\u2013gallate (EGCG) for the treatment of Alzheimer\u2019s disease. Int. J. Pharm. 2010;389:207\u2013212. doi: 10.1016/j.ijpharm.2010.01.012.", "ArticleIdList": ["10.1016/j.ijpharm.2010.01.012", "PMC5831366", "20083179"]}, {"Citation": "Cano A., Ettcheto M., Chang J.H., Barroso E., Espina M., K\u00fchne B.A., Barenys M., Auladell C., Folch J., Souto E.B., et al. Dual\u2013drug loaded nanoparticles of Epigallocatechin\u20133\u2013gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer\u2019s disease mice model. J. Control Release. 2019;301:62\u201375. doi: 10.1016/j.jconrel.2019.03.010.", "ArticleIdList": ["10.1016/j.jconrel.2019.03.010", "PMC6510952", "30876953"]}, {"Citation": "Cascella M., Bimonte S., Muzio M.R., Schiavone V., Cuomo A. The efficacy of Epigallocatechin\u20133\u2013gallate (green tea) in the treatment of Alzheimer\u2019s disease: An overview of pre\u2013clinical studies and translational perspectives in clinical practice. Infect. Agents Cancer. 2017;12:1\u20137. doi: 10.1186/s13027-017-0145-6.", "ArticleIdList": ["10.1186/s13027-017-0145-6", "PMC5477123", "28642806"]}, {"Citation": "Li F., Gong Q., Dong H., Shi J. Resveratrol, a neuroprotective supplement for Alzheimer\u2019s disease. Curr. Pharm. Des. 2012;18:27\u201333. doi: 10.2174/138161212798919075.", "ArticleIdList": ["10.2174/138161212798919075", "22211686"]}, {"Citation": "Kola A., Hecel A., Lamponi S., Valensin D. Novel perspective on Alzheimer\u2019s disease treatment: Rosmarinic acid molecular interplay with copper (II) and amyloid \u03b2. Life. 2020;10:118. doi: 10.3390/life10070118.", "ArticleIdList": ["10.3390/life10070118", "PMC7400086", "32698429"]}, {"Citation": "Noguchi-Shinohara M., Ono K., Hamaguchi T., Nagai T., Kobayashi S., Komatsu J., Samuraki-Yokohama M., Iwasa K., Yokoyama K., Nakamura H., et al. Safety and efficacy of Melissa officinalis extract containing rosmarinic acid in the prevention of Alzheimer\u2019s disease progression. Sci. Rep. 2020;10:18627. doi: 10.1038/s41598-020-73729-2.", "ArticleIdList": ["10.1038/s41598-020-73729-2", "PMC7596544", "33122694"]}, {"Citation": "Kumar A.P.S.N., Seghal N., Padi S.S.V. Neuroprotective effects of resveratrol against intracerebroventricular colchicine\u2013induced cognitive impairment and oxidative stress in rats. Pharmacol. Res. 2007;79:17\u201326. doi: 10.1159/000097511.", "ArticleIdList": ["10.1159/000097511", "17135773"]}, {"Citation": "Shekarchi M., Hajimehdipoor H., Saeidnia S., Gohari A.R., Hamedani M.P. Comparative study of rosmarinic acid content in some plants of Labiatae family. Pharmacogn. Mag. 2012;8:37\u201341.", "ArticleIdList": ["PMC3307200", "22438661"]}, {"Citation": "Petersen M., Simmonds M.S.J. Rosmarinic acid. Phytochemistry. 2003;62:121\u2013125. doi: 10.1016/S0031-9422(02)00513-7.", "ArticleIdList": ["10.1016/S0031-9422(02)00513-7", "12482446"]}, {"Citation": "Brodaty H., Corey-Bloom J., Potocnik F.C.V., Truyen L., Gold M., Damaraju C.R.V. Galantamine prolonged\u2013release formulation in the treatment of mild to moderate Alzheimer\u2019s disease. Dement. Geriatr. Cogn. Disord. 2005;20:120\u2013132. doi: 10.1159/000086613.", "ArticleIdList": ["10.1159/000086613", "15990426"]}, {"Citation": "Hathout R.M., El-Ahmady S.H., Metwally A.A. Curcumin or bisdemethoxycurcumin for nose\u2013to\u2013brain treatment of Alzheimer disease? A bio/chemo\u2013informatics case study. Nat. Prod. Res. 2018;32:2873\u20132881. doi: 10.1080/14786419.2017.1385017.", "ArticleIdList": ["10.1080/14786419.2017.1385017", "29022380"]}, {"Citation": "Yang F., Lim G.P., Begum A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., Chen P.P., Kayed R., Glabe C.G., Frautschy S.A., et al. Curcumin inhibits formation of amyloid \u03b2 oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 2005;280:5892\u20135901. doi: 10.1074/jbc.M404751200.", "ArticleIdList": ["10.1074/jbc.M404751200", "15590663"]}, {"Citation": "Shytle R.D., Bickford P.C., Rezai-zadeh K., Zeng H.L., Tan J., Sanberg P.R., Sanberg C.D., Roschek B., Fink R.C., Alberte R.S. Optimized turmeric extracts have potent anti-amyloidogenic effects. Curr. Alzheimer Res. 2009;6:564\u2013571. doi: 10.2174/156720509790147115.", "ArticleIdList": ["10.2174/156720509790147115", "19715544"]}, {"Citation": "Jomova K., Valko M. Importance of iron chelation in free radical-induced oxidative stress and human disease. Curr. Pharm. Des. 2011;17:3460\u20133473. doi: 10.2174/138161211798072463.", "ArticleIdList": ["10.2174/138161211798072463", "21902663"]}, {"Citation": "Bajda M., Guzior N., Ignasik M., Malawska B. Multi-target-directed ligands in Alzheimer\u2019s disease treatment. Curr Med Chem. 2011;18:4949\u20134975. doi: 10.2174/092986711797535245.", "ArticleIdList": ["10.2174/092986711797535245", "22050745"]}, {"Citation": "Cox K.H., Pipingas A., Scholey A.B. Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. J. Psychopharmacol. 2015;29:642\u2013651. doi: 10.1177/0269881114552744.", "ArticleIdList": ["10.1177/0269881114552744", "25277322"]}, {"Citation": "Chang W.C., Huang D.W., Lo Y.M., Tee Q.Q., Kuo P., Wu J.S., Huang W.C., Shen Z.C. Protective Effect of Caffeic Acid against Alzheimer\u2019s Disease Pathogenesis via Modulating Cerebral Insulin Signaling, beta\u2013Amyloid Accumulation, and Synaptic Plasticity in Hyperinsulinemic Rats. J. Agric. Food Chem. 2019;67:7684\u20137693. doi: 10.1021/acs.jafc.9b02078.", "ArticleIdList": ["10.1021/acs.jafc.9b02078", "31203623"]}, {"Citation": "Murata N., Murakami K., Ozawa Y., Kinoshita N., Irie K., Shirasawa T., Shimizu T. Silymarin attenuated the amyloid \u03b2 plaque burden and improved behavioral abnormalities in an Alzheimer\u2019s disease mouse model. Biosci. Biotechnol. Biochem. 2010;74:2299\u20132306. doi: 10.1271/bbb.100524.", "ArticleIdList": ["10.1271/bbb.100524", "21071836"]}, {"Citation": "Yaghmaei P., Azarfar K., Dezfulian M., Ebrahim-Habibi A. Silymarin effect on amyloid\u2013\u03b2 plaque accumulation and gene expression of APP in an Alzheimer\u2019s disease rat model. Daru. 2014;22:1\u20137. doi: 10.1186/2008-2231-22-24.", "ArticleIdList": ["10.1186/2008-2231-22-24", "PMC3904165", "24460990"]}, {"Citation": "Ganguli M., Chandra V., Kamboh M.I., Johnston J.M., Dodge H.H., Thelma B.K., Juyal R.C., Pandav R., Belle S.H., DeKosky S.T. Apolipoprotein E polymorphism and Alzheimer disease: The Indo\u2013US cross\u2013national dementia study. Arch. Neurol. 2000;57:824\u2013830. doi: 10.1001/archneur.57.6.824.", "ArticleIdList": ["10.1001/archneur.57.6.824", "10867779"]}, {"Citation": "Debbab A., Aly A.H., Lin W.H., Proksch P. Bioactive compounds from marine bacteria and fungi. Microb. Biotechnol. 2010;3:544\u2013563. doi: 10.1111/j.1751-7915.2010.00179.x.", "ArticleIdList": ["10.1111/j.1751-7915.2010.00179.x", "PMC3815768", "21255352"]}, {"Citation": "Abida H., Ruchaud S., Rios L., Humeau A., Probert I., Vargas C.D., Bach S., Bowler C. Bioprospecting marine plankton. Mar. Drugs. 2013;11:4594\u20134611. doi: 10.3390/md11114594.", "ArticleIdList": ["10.3390/md11114594", "PMC3853748", "24240981"]}, {"Citation": "Silva M., Seijas P., Otero P. Exploitation of Marine Molecules to Manage Alzheimer\u2019s Disease. Mar. Drugs. 2021;19:373. doi: 10.3390/md19070373.", "ArticleIdList": ["10.3390/md19070373", "PMC8307759", "34203244"]}, {"Citation": "Jin J.O., Yadav D., Madhwani K., Puranik N., Chavda V., Song M. Seaweeds in the Oncology Arena: Anti-Cancer Potential of Fucoidan as a Drug\u2014A Review. Molecules. 2022;27:6032. doi: 10.3390/molecules27186032.", "ArticleIdList": ["10.3390/molecules27186032", "PMC9506145", "36144768"]}, {"Citation": "Cowan C.M., Thai J., Krajewski S., Reed J.C., Nicholson D.W., Kaufmann S.H., Roskams J.A. Caspases 3 and 9 send a pro\u2013apoptotic signal from synapse to cell body in olfactory receptor neurons. J. Neurosci. 2001;21:7099\u20137109. doi: 10.1523/JNEUROSCI.21-18-07099.2001.", "ArticleIdList": ["10.1523/JNEUROSCI.21-18-07099.2001", "PMC6763014", "11549720"]}, {"Citation": "Luo D., Zhang Q., Wang H., Cui Y., Sun Z., Yang J., Zheng Y., Jia J., Yu F., Wang X., et al. Fucoidan protects against dopaminergic neuron death in vivo and in vitro. Eur. J. Pharmacol. 2009;617:33\u201340. doi: 10.1016/j.ejphar.2009.06.015.", "ArticleIdList": ["10.1016/j.ejphar.2009.06.015", "19545563"]}, {"Citation": "Cui Y.Q., Jia Y.J., Zhang T., Zhang Q.B., Wang X.M. Fucoidan protects against lipopolysaccharide-induced rat neuronal damage and inhibits the production of proinflammatory mediators in primary microglia. CNS Neurosci. Ther. 2012;18:827\u2013833. doi: 10.1111/j.1755-5949.2012.00372.x.", "ArticleIdList": ["10.1111/j.1755-5949.2012.00372.x", "PMC6493380", "23006515"]}, {"Citation": "Yoon J.H., Lee N., Youn K., Jo M.R., Kim H.R., Lee D.S., Ho C.T., Jun M. Dieckol ameliorates A\u03b2 production via PI3K/Akt/GSK\u20133\u03b2 regulated APP processing in SweAPP N2a Cell. Mar. Drugs. 2021;19:152. doi: 10.3390/md19030152.", "ArticleIdList": ["10.3390/md19030152", "PMC8001366", "33804171"]}, {"Citation": "Tsolaki M. Future strategies of management of Alzheimer\u2019s Disease. The role of homotaurine. Hell. J. Nucl. Med. 2019;22:82\u201394.", "ArticleIdList": ["30877726"]}, {"Citation": "Caltagirone C., Ferrannini L., Marchionni N., Nappi G., Scapagnini G., Trabucchi M. The potential protective effect of tramiprosate (homotaurine) against Alzheimer\u2019s disease: A review. Aging Clin. Exp. Res. 2012;24:580\u2013587.", "ArticleIdList": ["22961121"]}, {"Citation": "Jakaria M., Azam S., Haque M.E., Jo S.H., Uddin M.S., Kim I.S., Choi D.K. Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms. Redox. Biol. 2019;24:101223. doi: 10.1016/j.redox.2019.101223.", "ArticleIdList": ["10.1016/j.redox.2019.101223", "PMC6536745", "31141786"]}, {"Citation": "Otero P.A.Z., Alfonso A., Vieytes M.R., Cabado A.G., Vieites J.M., Botana L.M. Effects of environmental regimens on the toxin profile of Alexandrium ostenfeldii. Toxicol. Environ. Chem. 2010;29:301\u2013310. doi: 10.1002/etc.41.", "ArticleIdList": ["10.1002/etc.41", "20821448"]}, {"Citation": "Alonso E., Otero P., Vale C., Alfonso A., Antelo A., Gim\u00e9nez-Llort L., Chabaud L., Guillou C., Botana L.M. Benefit of 13\u2013desmethyl spirolide C treatment in triple transgenic mouse model of Alzheimer disease: Beta\u2013amyloid and neuronal markers improvement. Curr. Alzheimer Res. 2013;10:279\u2013289. doi: 10.2174/1567205011310030007.", "ArticleIdList": ["10.2174/1567205011310030007", "23036025"]}, {"Citation": "Suganthy N., Ramkumar V.S., Pugazhendhi A., Benelli G., Archunan G. Biogenic synthesis of gold nanoparticles from Terminalia arjuna bark extract: Assessment of safety aspects and neuroprotective potential via antioxidant, anticholinesterase, and antiamyloidogenic effects. Environ. Sci. Pollut. Res. 2018;25:10418\u201310433. doi: 10.1007/s11356-017-9789-4.", "ArticleIdList": ["10.1007/s11356-017-9789-4", "28762049"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "3", "Day": "20"}, {"Year": "2023", "Month": "4", "Day": "6"}, {"Year": "2023", "Month": "4", "Day": "9"}, {"Year": "2023", "Month": "4", "Day": "28", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "4", "Day": "28", "Hour": "6", "Minute": "41"}, {"Year": "2023", "Month": "4", "Day": "28", "Hour": "1", "Minute": "34"}, {"Year": "2023", "Month": "4", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["37109528", "PMC10144079", "10.3390/life13040999", "life13040999"]}}], "PubmedBookArticle": []}